Upload
others
View
7
Download
0
Embed Size (px)
Citation preview
Updated: May 29, 2014 -1-
CURRICULUM VITAE
ANDREA K. BIDDLE, PH.D.
Associate Professor
Department of Health Policy and Management
Gillings School of Global Public Health
University of North Carolina at Chapel Hill, CB#7411
Chapel Hill, North Carolina 27599-7411
Telephone: 919-966-7377 Facsimile: 919-966-3671
Electronic mail: [email protected]
EDUCATION
Degrees
1991 Ph.D., RAND Graduate School of Policy Studies, Public Policy Analysis.
1988 M.Phil., RAND Graduate School of Policy Studies, Public Policy Analysis.
1986 M.P.H., School of Public Health, University of Texas at Houston, Health Services
Organizations.
1984 B.S., cum laude, University of California at Los Angeles, Biochemistry.
PROFESSIONAL EXPERIENCE
2011-present Fellowship Director, UNC-Bristol Myers Squibb Global Health Outcomes Fellowship,
University of North Carolina at Chapel Hill, North Carolina.
2006-2010 Senior Lecturer, Department of Community Health, College of Medicine, University of
Malawi, Blantyre, Malawi.
2001-present Adjunct Associate Professor, Division of Pharmaceutical Policy and Evaluative
Sciences, School of Pharmacy, University of North Carolina at Chapel Hill, North
Carolina.
2001-present Research Fellow, Cecil G. Sheps Center for Health Services Research, University of
North Carolina at Chapel Hill, North Carolina.
2000-present Associate Professor, Department of Health Policy and Administration, School of Public
Health, University of North Carolina at Chapel Hill, North Carolina.
1993-2000 Center Associate, Cecil G. Sheps Center for Health Services Research, University of
North Carolina at Chapel Hill, North Carolina.
1992-2000 Assistant Professor, Department of Health Policy and Administration, School of Public
Health, University of North Carolina at Chapel Hill, North Carolina.
1991-1992 Visiting Assistant Professor, Department of Health Policy and Administration, School
of Public Health, University of North Carolina at Chapel Hill, North Carolina.
1987-1988 Graduate Student Instructor, RAND Graduate School of Policy Studies, Sloan
Foundation Senior Summer Institute, and the Pew Policy Career Development
Fellowship Program, Santa Monica, California.
1986-1989 Health Policy Research Fellow and Consultant, The RAND/UCLA Center for Health
Policy Study, The RAND Corporation, Santa Monica, California.
1986 Research Consultant, Audie L. Murphy Veterans Administration Hospital, San Antonio,
Texas; Center for Health Promotion Research and Development, The University of Texas
at Houston, Texas.
Updated: May 29, 2014 -2-
1985-1986 Research Assistant, Center for Health Promotion Research and Development, The
University of Texas at Houston, Texas.
1985 Research Intern, Public Health Promotion Division, Texas Department of Health,
Austin, Texas.
1985 Research Intern, Center for Health Promotion and Education, Centers for Disease
Control, Atlanta, Georgia.
HONORS
2002 2002 Mark S. Ehrenreich Prize in Healthcare Ethics Research, Pacific Center for Health
Policy and Ethics, University of Southern California for “Will Insured Minnesotans Give
Up Benefit Coverage to Include the Uninsured? (Susan Dorr Goold, Stephen A. Green,
Andrea K. Biddle, Ellen Benavides, and Marion Danis)
1996-present Delta Omega Graduate Public Health Honor Society
1989-1990 RAND Graduate School Policy Studies Fellowship
1986-1990 Pew Memorial Trust Fund Fellowship
1985-1986 Delegate, The University of Texas System Board of Regents
1985-1986 President, The University of Texas at Houston, Student Intercouncil
1984-1986 United States Public Health Service Traineeship
1980-1981 University of California at Los Angeles Chancellor’s Scholarship
RESEARCH ACCOMPLISHMENTS
BOOK CHAPTER
(* Indicates Health Policy and Management student, † Indicates other student)
1. *Winghan Jacqueline Kwong, Andrea K. Biddle, Ya-Chen Tina Shih. “Cost Benefit Analysis of
Sumatriptan Tablets versus Usual Non-triptan Therapy for the Treatment of Migraine.” In Reducing
the Burden of Headache, Frontiers in Headache Research, Volume 11 (Oleson J, T Steiner, and R
Lipton, eds.). Oxford: Oxford University Press, 2002.
REFEREED ARTICLES, MONOGRAPHS, AND PUBLISHED ABSTRACTS (* Indicates Health Policy and Management student, † Indicates other student)
Articles:
1. †Katherine Reeder-Hayes, Stephanie B. Wheeler, Andrea K. Biddle. “Cost-effectiveness of adjuvant
radiotherapy added to hormonal therapy for the treatment of older women with early breast cancer.”
Revise and Resubmit, Journal of Clinical Oncology.
2. *Michaela A. Dinan, Lesley H. Curtis, William R. Carpenter, Andrea K. Biddle, Amy P. Abernethy,
Edward F. Patz, Kevin A. Schulman, Morris Weinberger. “Redistribution of health care costs after
the adoption of positron emission tomography among Medicare beneficiaries with non-small-cell lung
cancer, 1998-2005.” Journal of Thoracic Oncology, 2014 Apr;9(4):512-8. doi:
10.1097/JTO.0000000000000102.
3. *Dio Kavalieratos, Arif H. Kamal, Amy P. Abernethy, Andrea K. Biddle, Timothy S. Carey, Sandesh
Dev, Bryce B. Reeve, Morris Weinberger. “Comparing unmet needs between community-based
palliative care patients with heart failure and patients with cancer.” Journal of Palliative Medicine,
2014 Apr;17(4):475-81. doi: 10.1089/jpm.2013.0526. Epub 2014 Mar 3.
Updated: May 29, 2014 -3-
4. *Dio Kavalieratos, Emma M. Mitchell, Andrea K. Biddle, Timothy S. Carey, Sandesh Dev, Bryce B.
Reeve, Amy P. Abernethy, Morris Weinberger. “Not the ‘grim reaper service’”: an assessment of
proivider knowledge, attitudes, and perceptions regarding palliative care referral barriers in heart
failure.” Journal of the American Heart Association, 2014 Jan 2;3(1):e000544. doi:
10.1161/JAHA.113.000544.
5. *Alice K. Fortune-Greeley, Stephanie B. Wheeler, Anne-Marie Meyer, Katherine E. Reeder-Hayes,
Andrea K. Biddle, Hyman B. Muss, William R. Carpenter. “Preoperative breast MRI and surgical
outcomes in elderly women with invasive ductal and lobular carcinoma: a population-based study.”
Breast Cancer Research and Treatment, 2014 Jan;143(1):203-12. doi: 10.1007/s10549-013-2787-4.
Epub 2013 Dec 4.
6. *Ramzi G. Salloum, Gail A. Jensen, Raquel Kelly Kohler, Stacy Sheridan, Andrea K. Biddle. “U.S.
Preventive Services Task Force Recommendations and cancer screening among female Medicare
beneficiaries.” Journal of Women’s Health, 2014 Mar;23(3):211-7. doi: 10.1089/jwh.2013.4421.
Epub 2013 Nov 6.
7. *Sarah E. Rutstein, Lillian B. Brown, Andrea K. Biddle, Stephanie B. Wheeler, Gift Kamanga,
Pearson Mmodzi, Naomi Niyrenda, Innocent Mofolo, Nora E. Rosenberg, Irving F. Hoffman,
William C. Miller. “Cost-effectiveness of provider-based HIV partner notification in urban Malawi.”
Health Policy and Planning, 2013 Jan 15 [Epub ahead of time]. 2014 Jan;29(1):115-26. doi:
10.1093/heapol/czs140. Epub 2013 Jan 15.
8. †Taewoo Lee, Andrea K. Biddle, Sean Barbour, Sofia Lionaki, Yichun Hu, Vimal K. Derebail,
Michelle Hladunewich, Jennette C.E., Shannon Mahoney, J. Caroline Jennette, Susan L. Hogan,
Ronald J. Falk, Daniel C. Cattran, Heather N. Reich, Patrick H. Nachman. Prophylactic
anticoagulation in patients with membranous nephropathy: A decision analysis.” Kidney
International, 2013 Dec 11 doi: 10.1038/ki.2013.476. [Epub ahead of print].
9. *Laurel C. Trantham, Matthew Nielsen, Leigh R. Mobley, Stephanie B. Wheeler, William R.
Carpenter, Andrea K. Biddle. “Use of prostate-specific antigen testing as a disease surveillance tool
following radical prostatectomy.” Cancer 2013 Oct 1;119(19):3523-30. doi: 10.1002/cncr.28238.
Epub 2013 Jul 24.
10. *Ramzi G. Salloum, Gail A. Jensen, Andrea K. Biddle. “The ‘Welcome to Medicare Visit’: A missed
opportunity for cancer screening among women?” Journal of Women’s Health, 2013;22(1):19-26.
11. *Daniel Belsky, Terrie E. Moffitt, Renate Houts, Gary B. Bennett, Andrea K. Biddle, James P. Evans,
Hona Lee Harrington, Karen Sugden, Benjamin Williams, Madeline Meier, Avshalom Caspi.
“Polygenic risk and the developmental progression to heavy, persistent smoking and nicotine
dependence: Evidence from a 4-decade longitudinal study.” JAMA Psychiatry, 2013;70(5):534-42.
12. *Michaela A. Dinan, Lesley H. Curtis, William R. Carpenter, Andrea K. Biddle, Amy P. Abernethy,
Edward F. Patz, Kevin A. Schulman, Morris Weinberger. “Variations in the use of PET among
Medicare beneficiaries with non-small-cell lung cancer, 1998-2007.” Radiology, 2013;267(3):807-17.
doi: 10.1148/radiol.12120174. Epub 2013 Feb 15.
13. Lori A. Bastian, Laura J. Fish, Bercedis L. Peterson, Andrea K. Biddle, Jennifer Garst, Pauline Lyna,
Stephanie Molner, Gerold Bepler, Mike Kelley, Francis J. Keefe, Colleen M. McBride.
“Assessment of the impact of adjunctive proactive telephone counseling to promote smoking
cessation among lung cancer patients’ social networks.” American Journal of Health Promotion,
2013;27(3):181-90.
14. *Michaela A. Dinan, Lesley H. Curtis, William R. Carpenter, Andrea K. Biddle, Amy P. Abernethy,
Edward F. Patz, Kevin A. Schulman, and Morris Weinberger. “Stage migration, selection bias, and
survival associated with the adoption of PET among Medicare beneficiaries with non-small-cell lung
cancer, 1998-2003”. Journal of Clinical Oncology, 2012;30(22):272-30.
15. *Stephanie B. Wheeler, William R. Carpenter, Jeffrey Peppercorn, Anna P. Schenck, Morris
Weinberger, Andrea K. Biddle. “Structural/organizational characteristics of health services partly
explain timeliness of radiation therapy in elderly breast cancer patients.” Breast Cancer Research and
Treatment, 2012;133(1):333-45.
Updated: May 29, 2014 -4-
16. *Daniel Belsky, Terrie E. Moffitt, Renate Houts, Gary B. Bennett, Andrea K. Biddle, James A.
Blumenthal. Hona Lee Harrington, Karen Sugden, Benjamin Williams, Richie Poulton, Avshalom
Caspi. “Polygenic risk, rapid childhood growth, and the development of obesity: Evidence from a 4-
decade longitudinal study.” Archives of Pediatric & Adolescent Medicine, 2012;166(6):515-21.
17. †JaHyun Kang, Paul Mandsager, Andrea K. Biddle, David J. Weber. “Cost-effectiveness analysis of
active surveillance screening for methicillin-resistant Staphylococcus aureus in a tertiary hospital
setting.” Infection Control and Hospital Epidemiology, 2012;33(5):477-86.
18. *Stephanie B. Wheeler, William R. Carpenter, Jeffrey Peppercorn, Anna P. Schenck, Morris
Weinberger, Andrea K. Biddle. “Predictors of timing of adjuvant chemotherapy in older women with
hormone receptor-negative, stages II-III breast cancer.” Breast Cancer Research and Treatment,
2012;131(1):207-16.
19. Susan Evans-Lacko, Susan Dorr Goold, Marion Danis, Andrea K. Biddle. “Layperson’s choices and
deliberations for mental health coverage”. Administration and Policy in Mental Health and Mental
Health Services Research, 2012;39(3):158-169.
20. Lori A. Bastian, Laura J. Fish, Bercedis L. Peterson, Andrea K. Biddle, Jennifer Garst, Pauline Lyna,
Stephanie Molner, Gerold Bepler Michael Kelley, Francis K. Keefe, Colleen M. McBride. Proactive
recruitment of cancer patients’ social networks into a smoking cessation trial. Contemporary Clinical
Trials, 2011;32(4):498-504.
21. *Daniel J. Crespin, Jerome J. Federspiel, Andrea K. Biddle, Daniel E. Jonas, Joseph S. Rossi.
“Ticagrelor versus genotype-driven antiplatelet therapy for secondary prevention after acute coronary
syndrome: A cost-effectiveness analysis.” Value in Health, 2011;14(4):483-91.
22. *Pei-Jung Lin, Daniel I. Kaufer, Matthew L. Maciejewski, John E. Paul, Andrea K. Biddle. “Risk
adjustment for Medicare beneficiaries with Alzheimer’s Disease and related dementias”. American
Journal of Managed Care, 2010;16(3):191-8.
23. *Pei-Jung Lin, Daniel I. Kaufer, Matthew L. Maciejewski, Rahul Ganguly, John E. Paul, Andrea K.
Biddle. “Identifying community-dwelling individuals with Alzheimer’s Disease from observational
data”. Alzheimer’s & Dementia: Journal of the Alzheimer’s Association, 2010;6(4):334-41.
24. Marcy K. Campbell, Carol Carr, Bob DeVellis, Boyd Switzer, Andrea Biddle, Monique Ahinee
Amamoo, Joan Walsh, Bingqing Zhou, Robert Sandler. “A randomized trial of tailoring and
motivational interviewing to promote fruit and vegetable consumption for cancer prevention and
control”. Annals of Behavioral Medicine. 2009;38(2):71-85.
25. *Pei-Jung Lin, Andrea K. Biddle, Rahul Ganguly, Daniel I. Kaufer, Matthew L. Maciejewski. “The
concentration and persistence of health care expenditures and prescription drug expenditures in
Medicare beneficiaries with Alzheimer’s Disease”. Medical Care, 2009;47(11):1174-79.
26. †Sylvia I. Becker-Dreps, Andrea K. Biddle, Audrey C. Pettifor, Gertrude Musuamba, David Nku
Imbie, Vera Melotte, Steven Meshnick. “Cost-effectiveness of adding insecticide-treated bednet
distribution for malaria prevention to a vertical HIV transmission prevention program”. American
Journal of Tropical Medicine and Hygiene. 2009;81(3):496-502.
27. *†Andrea K. Biddle, Suzanne L. West, Aimee A. D’Alosio, Stephanie B. Wheeler, Natalie Borisova,
John Thorp. “The humanistic burden of surgical menopause: results of a national survey”. Value in
Health. 2009;12(5):763-772.
28. *Manabu Akazawa, Andrea K. Biddle, Sally C. Stearns. “Economic assessment of early initiation of
inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching”
Clinical Therapeutics, 2008;30(Theme issue):1003-1016.
29. *Manabu Akazawa, Sally C. Stearns, Andrea K. Biddle. “Assessing treatment effects of inhaled
corticosteroid on medical costs among COPD patients: Longitudinal analysis of managed care
claims.” Health Services Research 2008;43(6):2164-82.
30. †Laura Linnan, John Rose, Victoria Carlisle, Kelly Evenson, E.G. Hooten, EG, Ayanna Mangum,
Alice Ammerman, Kant Bangdiwala, Kelly Hansen, Margaret Bentley, Andrea Biddle. The North
Carolina BEAUTY and health project: Overview and baseline results. The Community Psychologist.
2007;40(2):61-66.
Updated: May 29, 2014 -5-
31. *Rachael L. DiSantostefano, Andrea K. Biddle, John Lavelle. “An evaluation of the economic costs
and patient-related consequences of treatments for benign prostatic hyperplasia” British Journal of
Urology International, 2006;97:1007-1016.
32. *Rachael L. DiSantostefano, Andrea K. Biddle, John Lavelle. “The long-term cost-effectiveness of
treatments for benign prostatic hyperplasia”. PharmacoEconomics, 2006; 24(2):171-191.
33. *Joanne R. Campione, Betsy Sleath, Andrea K. Biddle, Morris Weinberger. “The influence of
physician guideline compliance on patient statin adherence”. The American Journal of Geriatric
Pharmacotherapy, 2005;3(4):229-239.
34. Susan Dorr Goold, Andrea K. Biddle, Glenn Klipp, Charles N. Hall, Marion Danis. “Choosing
Healthplans All Together: A deliberative exercise for allocating limited health care resources”.
Journal of Health Policy, Politics, and Law, 2005 Aug; 30(4):563-601.
35. *Rachael L. DiSantostefano, Andrea K. Biddle, John P. Lavelle. “An economic evaluation of
doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia”.
(Letter) Canadian Journal of Urology. 2005; 12(1):2508-9; author reply 2509-10.
36. *Elinor C.G. Chumney, Andrea K. Biddle, Kit N. Simpson, Morris Weinberger, Kathryn M.
Magruder, William N. Zelman. “The effect of cost construction based on either DRG or ICD-9 codes
or risk group stratification on the resulting cost-effectiveness ratios”. PharmacoEconomics, 2004;
22(18): 1209-1216.
37. Marion Danis, Andrea K. Biddle, Susan Dorr Goold. “Enrollees choose priorities for Medicare”. The
Gerontologist, 2004; 44(1):58-67.
38. Susan Dorr Goold, Stephen A. Green, Andrea K. Biddle, Ellen Benavides, Marion Danis. “Will
insured citizens give up benefit coverage to include the uninsured?” Journal of General Internal
Medicine, 2004; 19(8): 868-874.
39. †Christopher E. Cox, Shannon S. Carson, Andrea K. Biddle. “Cost-Effectiveness of Ultrasound
Screening in Preventing Femoral Vein Catheter-Associated Pulmonary Embolism”. American
Journal of Critical Care and Respiratory Medicine, 2003; 168: 1481-7 (*Note: senior author
position).
40. *Elinor C.G. Chumney, Andrea K. Biddle, Kit N. Simpson. “Survey of acceptable variations in cost-
effectiveness ratios: A brief overview”. ISPOR Connections, 2003; 9(5): 13.
41. Marion Danis, Andrea K. Biddle, Susan Dorr Goold. “Insurance preferences of the low-income
uninsured”. Journal of General Internal Medicine, 2002; 17(2):125-133.
42. †Kathryn Andersen Clark, Andrea K. Biddle, Sandra L. Martin. “A cost-benefit analysis of the
Violence Against Women Act of 1994”. Violence Against Women, 2002; 8(4):417-428.
43. *David J. Harrison, Andrea K. Biddle. Letter to the Editor re: “Lack of health insurance and overall
health”. New England Journal of Medicine. 2002; 346(8):626-627.
44. Consortium for Spinal Cord Medicine. “Pressure ulcer prevention and treatment following spinal
cord injury: a clinical practice guideline for health-care professionals”. Journal of Spinal Cord
Medicine, 2001;24(Suppl 1):S40-S101.
45. *Andrea K. Biddle, Ya-Chen Tina Shih, Winghan Jackie Kwong. “Cost-benefit analysis of
sumatriptan tablets versus usual therapy for the treatment of migraine”. Pharmacotherapy 2000;
20(11):1356-1364.
46. *James F. Helm, Mark W. Russo, Andrea K. Biddle, Kit N. Simpson, David F. Ransohoff, Robert S.
Sandler. “Effectiveness and economic impact of a concerted effort to implement mass fecal occult
blood testing”. American Journal of Gastroenterology, 2000: 95(11):325-8.
47. Andrea K. Biddle, Kit N. Simpson. “Modelling the use of nevirapine triple combination therapy in
five countries”. Value in Health 2000; 3(3): 186-202.
48. *Deborah A. Marshall, Kit N. Simpson, Edward C. Norton, Andrea K. Biddle, Michael C. Youle.
“Measuring the effect of clinical guidelines on patient outcomes”. International Journal of
Technology Assessment in Health Care, 2000; 16(4): 1010-20.
49. Andrea K. Biddle, Erin P. Fraher. “Developing clinical practice guidelines for spinal cord medicine:
Lessons learned”. Physical Medicine and Rehabilitation Clinics of North America 2000;11(1):227-
243.
50. Rebecca T. Slifkin, Victoria A. Freeman, Andrea K. Biddle. “Costs of developing immunization
Updated: May 29, 2014 -6-
registries: Case studies from four All Kids Count projects”. Journal of Public Health Practice and
Management 1999;5(5):67-81.
51. Ya-Chen Tina Shih, Teresa L. Kauf, Andrea K. Biddle, Kit N. Simpson. “Incorporating problem-
based learning concepts into a lecture-based pharmacoeconomics course”. American Journal of
Pharmaceutical Education 1999;63(2):152-159. (Also listed in the Teaching Section of this
Curriculum Vitae.)
52. Andrea K. Biddle, Kit N. Simpson. “The use of nevirapine triple combination therapy in the United
Kingdom: Estimates of the short-term cost-offset and cost-effectiveness”. Journal of Medical
Economics 1999;2:85-105.
53. †Steven L. Zacks, Robert S. Sandler, Andrea K. Biddle, Mark A. Mauro, Robert S. Brown, Jr.
“Decision-analysis of transjugular intrahepatic portosystemic shunt versus distal splenorenal shunt for
portal hypertension in Child’s A cirrhosis”. Hepatology 1999;29:1399-1405.
54. †Allison B. Rosen, Vance G. Fowler, Jr., George R. Corey, Stephen M. Downs, Andrea K. Biddle,
Jennifer Li, James G. Jollis. “Cost-effectiveness of transesophageal echocardiography in determining
the duration of therapy for patients with intravascular catheter-associated Staphylococcus aureus
bacteremia”. Annals of Internal Medicine 1999;130(10):810-820.
55. Rosemarie B. King, Andrea K. Biddle, Carol Braunschweig, David Chen, Fred Cowell, C. Mary
Dingus, Margaret C. Hammond, Cindy Hartley, Walter E. Longo, Peggy Matthews Kirk, Audrey
Nelson, Steven A. Stiens. “Neurogenic bowel management in adults with spinal cord injury.
Consortium for Spinal Cord Medicine clinical practice guideline”. Journal of Spinal Cord Medicine
1998;21(3):248-293.
56. *Andrea K. Biddle, Robert F. DeVellis, Gail Henderson, Sarah Boyce Fasick, Marion Danis. “The
health insurance puzzle: A new approach to assessing patient coverage preferences”. Journal of
Community Health 1998;23(3):181-194.
57. Andrea K. Biddle. Commentary on Josephine A. Mauskopf, et al., “Economic impact of treatment of
HIV-positive pregnant women and their newborns with zidovudine. Implications for HIV screening”.
Journal of the American Medical Association 1996;276(2):132-138. Published in Journal of
Pediatrics 1997;130(1):159.
58. *Gary L. Freed, Sarah J. Clark, Donald E. Pathman, T. Robert Konrad, Andrea K. Biddle, Robin M.
Schectman. “Impact of a new universal purchase vaccine program in North Carolina”. Archives of
Pediatric and Adolescent Medicine 1997;151(11):1117-1124.
59. Todd Linsenmeyer, Andrea K. Biddle, Diana Cardenas, Judi Kuric, Thomas Mobley, Inder Perkash,
Kit N. Simpson, Cynthia Zejdlik. “Acute management of autonomic dysreflexia. Consortium for
Spinal Cord Medicine clinical practice guideline”. Journal of Spinal Cord Medicine 1997;20(3):284-
310.
60. David Green, Andrea K. Biddle, Victoria Fahey, Geoffrey A. Gardiner, Jr., Russell Hull, Michael Y.
Lee, Geno J. Merli, Kurt Mossberg, Graham Pineo, Kristjan Ragnarsson, David Rosenblum, Kit N.
Simpson, Jonathon R. Strayer. “Prevention of thromboembolism in spinal cord injury. Consortium
for Spinal Cord Medicine clinical practice guideline”. Journal of Spinal Cord Medicine
1997;20(3):259-283.
61. Marion Danis, Andrea K. Biddle, Gail Henderson, Joanne M. Garrett, Robert F. DeVellis. “Elderly
Medicare enrollees' choices for insured services”. Journal of the American Geriatrics Society
1997;45(6):688-694 (accompanied by an editorial).
62. *Andrea K. Biddle, Sarah E. Boyce, Deepika Nimmagadda. “Uninsured workers in North Carolina:
Who is at risk?” Carolina Health Services Review 1997;4:41-53.
63. *Jeanne M. Lambrew, Gordon H. DeFriese, Timothy S. Carey, Thomas C. Ricketts, Andrea K.
Biddle. “The effect of having a regular doctor on access to care: Results using the Institute of
Medicine's indicators of access to primary care”. Medical Care 1996;34(2):138-151.
64. Kit N. Simpson, Andrea K. Biddle, N. Regina Rabinovich. “A model for estimating the impact of
changes in children's vaccines”. American Journal of Public Health 1995;85(12):1666-1672
(accompanied by an editorial).
65. Carole Oken, Nancy Archibald, Marilyn Cvitanic, Andrea K. Biddle, Martin F. Shapiro, Charles L.
Bennett. “Multi-city study of quality of care for HIV-related Pneumocystis carinii pneumonia:
Updated: May 29, 2014 -7-
Successfully collecting highly sensitive information”. Clinical Performance and Quality Health Care
1995;3(3):140-146.
66. *Julie C. Jacobson Vann, Andrea K. Biddle, Charles W. Daeschner, Sara Chaffee, Stuart H. Gold.
“Health insurance access to young adult survivors of childhood cancer in North Carolina”. Medical
and Pediatric Oncology 1995;25(5):389-95.
67. Gerald F. Kominski, Andrea K. Biddle. “Changes in follow-up care for Medicare surgical patients
under PPS”. Medical Care 1993;31(3):230-246.
68. Charles E. Begley, Andrea K. Biddle. “The cost-effectiveness of safety belts in school buses: A
prospective analysis". Public Health Reports 1988;103(5):479-485.
69. Patricia D. Mullen, Nell H. Gottlieb, Andrea K. Biddle, Richard A. McCuan, Alfred L. McAlister.
“Predictors of safety belt initiative by primary care physicians: A social learning theory perspective”.
Medical Care 1988;26(4):373-382.
70. Patricia D. Mullen, Elizabeth A. LaVille, Andrea K. Biddle, Kate Lorig. “"Efficacy of
psychoeducational intervention on pain, depression, and disability with arthritic adults: A meta-
analysis”. Journal of Rheumatology 1987;14 (Suppl 15):33-39.
71. Patricia D. Mullen, Irene Easling, Sam A. Nixon, Donald R. Koester, Andrea K. Biddle. “The cost-
effectiveness of randomized incentive and follow-up contacts in a national mail survey of family
physicians”. Evaluation and the Health Professions 1987;10(2):232-245.
Monographs:
1. Andrea K. Biddle, Linda R. Watson, Celia R. Hooper, Kathleen N. Lohr, Sonya F. Sutton. Criteria
for Determining Disability in Speech and Language Disorders. Evidence Report/Technology
Assessment No. 52. (Prepared by the RTI-University of North Carolina at Chapel Hill Evidence-based
Practice Center under Contract No 290-97-0011). AHRQ Publication No. 02E010. Rockville, MD:
Agency for Healthcare Research and Quality, January 2002.
2. Andrea K. Biddle, Linda R. Watson, Celia R. Hooper, Kathleen N. Lohr. Final Evidence Report for
Criteria for Determining Disability in Speech and Language Disorders. Agency for Healthcare
Research and Quality and the Social Security Administration, November 2001.
3. Andrea K. Biddle, Linda R. Watson, Celia R. Hooper, Kathleen N. Lohr. Draft Evidence Report for
Criteria for Determining Disability in Speech and Language Disorders. Agency for Healthcare
Research and Quality and the Social Security Administration, August 2001.
4. Consortium for Spinal Cord Medicine. Prevention and Treatment of Pressure Ulcers in Persons with
Spinal Cord Injury: Clinical Practice Guidelines for Spinal Cord Medicine. Washington, DC:
Paralyzed Veterans of America, August 2000.
5. Gale G. Whitneck, Carole Adler, Andrea K. Biddle, Sharon Blackburn, Michael J. DeVivo, Stephen
M. Haley, Robert D. Hendricks, Allen W. Heinemann, Kelly Johnson, Ralph J. Mario, Harley
Thomas, Robert L. Waters, Gary M. Yarkony. Outcomes Following Traumatic Spinal Cord Injury:
Consortium for Spinal Cord Medicine Clinical Practice Guideline. Washington, DC: Paralyzed
Veterans of America, July 1999.
6. Rosemarie B. King, Andrea K. Biddle, Carol Braunschweig, David Chen, Fred Cowell, C. Mary
Dingus, Margaret C. Hammond, Cindy Hartley, Walter E. Longo, Peggy Matthews Kirk, Audrey
Nelson, Steven A. Stiens. Neurogenic Bowel Management in Adults with Spinal Cord Injury.
Consortium for Spinal Cord Medicine Clinical Practice Guideline. Washington, DC: Paralyzed
Veterans of America, April 1998.
7. Todd Linsenmeyer, Andrea K. Biddle, Diana Cardenas, Judi Kuric, Thomas Mobley, Inder Perkash,
Kit N. Simpson, Cynthia Zejdlik. Acute Management of Autonomic Dysreflexia. Consortium for
Spinal Cord Medicine Clinical Practice Guideline. Washington, DC: Paralyzed Veterans of America,
February 1997.
8. David Green, Andrea K. Biddle, Victoria Fahey, Geoffrey A. Gardiner, Jr., Russell Hull, Michael Y.
Lee, Geno J. Merli, Kurt Mossberg, Graham Pineo, Kristjan Ragnarsson, David Rosenblum, Kit N.
Updated: May 29, 2014 -8-
Simpson, Jonathon R. Strayer. Prevention of Thromboembolism in Spinal Cord Injury. Consortium
for Spinal Cord Medicine Clinical Practice Guideline. Washington, DC: Paralyzed Veterans of
America, February 1997.
Published Abstracts:
1. *Pei-Jung Lin, Andrea K. Biddle, Rahul Ganguly, Daniel I. Kaufer, Matthew L. Maciejewski, John E.
Paul. Identifying community-dwelling individuals with Alzheimer’s disease using observational data.
Alzheimer's and Dementia 2008;4(4,Suppl 1):T678.
2. *Rachel L. DiSantostefano, Andrea K. Biddle, John P. Lavelle. “Cost-effectiveness analysis of
benign prostatic hyperplasia treatments”. Value in Health 2005;8(3): 301.
3. Susan Dorr Goold, Andrea K. Biddle, Glenn Klipp, Marion Danis. “Choosing Healthplans All
Together: A game to assess consumer values and preferences for health insurance”. Journal of
General Internal Medicine 2001:16(Suppl 1).
4. Marion Danis, Andrea K. Biddle, Susan Dorr Goold. “Insurance preferences of the uninsured”.
Journal of General Internal Medicine 2001:16(Suppl 1).
5. †Yu-Chen Yeh, Andrea K. Biddle, Abraham G. Hartzema. “Cost-effectiveness analysis of
lamivudine treatment in chronic hepatitis B.” Value in Health 2000;3(2):124.
6. Andrea K. Biddle, Kit N. Simpson. “Modelling the use of triple combination therapy in five
countries: Nevirapine, zidovudine, and didanosine”. AIDS 1998;23(4 Supplement):S59.
7. Andrea K. Biddle, Kit N. Simpson. “Modelling the use of nevirapine triple combination therapy in
the United Kingdom: An economic evaluation”. AIDS 1998;23(4 Supplement):S59.
8. *Laurie J. Goldsmith, Andrea K. Biddle, Robert S. Brown, Jr. “Cost-effectiveness analysis of
prophylactic therapies for CMV disease after liver transplantation”. Hepatology 1998;28(4 Part
2):350A.
9. Marion Danis, Andrea K. Biddle, Gail Henderson, Joanne M. Garrett, Robert F. DeVellis. “Elderly
Medicare enrollees' choices for insured services”. Journal of General Internal Medicine
1996;11(Supplement):67.
REFEREED, UNPUBLISHED ORAL PRESENTATIONS OR ABSTRACTS (* Indicates Health Policy and Management student, † Indicates other student)
1. Angela B. Smith, Mrdula S. Borse, Nnamaeke C. Modebe, , Matthew E. Nielsen, Raj S. Pruthi,
David C. Johnson, Eric M. Wallen, Michael E. Woods, Matthew I. Milowsky, Ronald C. Chen,
Andrea K. Biddle. “Cost-utility analysis of cystectomy vs. chemo-radiation for treatment of muscle-
invasive bladder cancer in the elderly”. (Poster presentation). International Society for
Pharmacoeconomics and Outcomes Research, Montreal Canada, 3 June 2014.
2. †Yi-Ting Chou, Andrea K. Biddle. “Cost-effectiveness of pharmacotherapy for children and
adolescents with attention deficit hyperactivity disorder”. (Poster presentation). International Society
for Pharmacoeconomics and Outcomes Research, Montreal Canada, 3June 2014.
3. †Taewoo Lee, Andrea K. Biddle, Sean Barbour, Sofia Lionaki, Yichun Hu, Vimal K. Derebail,
Michelle Hladunewich, Jennette C.E., Shannon Mahoney, J. Caroline Jennette, Susan L. Hogan,
Ronald J. Falk, Daniel C. Cattran, Heather N. Reich, Patrick H. Nachman. “Prophylactic
Anticoagulation in patients with membranous nephropathy: A decision analysis”. (Oral presentation),
American Society for Nephrology, San Diego, CA, 2 November 2012.
4. †Julie Lauffenburger, Andrea K. Biddle. “Comparative effectiveness of apixaban for stroke
prevention in atrial fibrillation in older adults”. (Poster Presentation). AcademyHealth Research
Meeting, Orlando, FL, 24-26 June 2012.
5. †Katie Reeder-Hayes, Stephanie B. Wheeler, Andrea K. Biddle. “Cost-effectiveness of adjuvant
radiotherapy added to hormonal therapy for the treatment of older women with early breast cancer”.
(Poster Presentation). AcademyHealth Research Meeting, Orlando, FL, 24-26 June 2012.
Updated: May 29, 2014 -9-
6. † Melea G. Ward, Andrea K. Biddle. “Cost-effectiveness analysis of dabigatran compared to warfarin
for the stroke prevention in atrial fibrillation in a Medicare population”. (Poster Presentation).
International Society for Pharmacoeconomics and Outcomes Research, Washington, DC, 5 June
2012.
7. †Rishi J. Desai, Jaya K. Rao, Andrea K. Biddle. “Cost-effectiveness analysis of golimumab for the
treatment of rheumatoid arthritis”. (Poster Presentation) International Society for
Pharmacoeconomics and Outcomes Research, Washington, DC, 4 June 2012.
8. †Ravi K. Goyal, Anne-Marie Meyer, Nathan C. Sheets, Jerome J. Federspiel, William R. Carpenter,
Ronald C. Chen, Andrea K. Biddle. “Cost-utility of proton therapy in the treatment of localized
prostate cancer”. (Electronic Publication), American Society of Clinical Oncology, Chicago, IL. 1-5
June 2012.
9. †Katherine Elizabeth Reeder-Hayes, Stephanie B. Wheeler, Andrea K Biddle. “Cost-effectiveness of
adjuvant radiotherapy for older women with early hormone-receptor positive breast cancer”. (Poster
Presentation). American Society of Clinical Oncology, Chicago, IL, 1-5 June 2012.
10. †Michael T. Benigno, Zulfiya Chariyeva, Laura M. Gibney, Patricia A. McLaughlin, Habtamu Gurmu
Negash, Marsha A. Hamilton, Andrea K. Biddle. “The Cost-effectiveness of Ethiopian mother
support groups in preventing vertical transmission of HIV”. (Poster Presentation). International
Conference on AIDS and STIs in Africa, Addis Ababa, Ethiopia, 4-8 December 2011.
11. †JaHyun Kang, Paul Mandsager, Andrea K. Biddle, David J. Weber. “Cost-effectiveness analysis of
active surveillance screening for methicillin-resistant Staphylococcus aureus in a tertiary hospital
setting”. (Poster Presentation). Association of Professionals in Infection Control, Baltimore, MD, 27-
29 January 2011.
12. *Daniel J. Crespin, Jerome J. Federspiel, Andrea K. Biddle, Daniel E. Jonas, Joseph S. Rossi.
“Ticagrelor versus genotype-driven antiplatelet therapy for secondary prevention after acute coronary
syndrome: A cost-effectiveness analysis”. (Poster Presentation). International Society for
PharmacoEconomics and Outcomes Research, Atlanta, Georgia, 15-19 May 2010.
13. †David N. Wei, Ching-ching Lin, Andrea K. Biddle “Cost-Effectiveness of cetuximab among elderly
metastatic colorectal cancer patients”. (Poster Presentation). International Society for
PharmacoEconomics and Outcomes Research, Atlanta, Georgia, 15-19 May 2010.
14. *Pei-Jung Lin, Matthew L. Maciejewski, John E. Paul, Andrea K. Biddle. “Risk adjustment for
Medicare beneficiaries with Alzheimer’s disease and related dementias”. (Poster Presentation)
AcademyHealth, Chicago, Illinois, 28-30 June 2009.
15. †Chi-Chuan Wang, Andrea K. Biddle, Joel F. Farley. “Cost-effectiveness of ezetimibe/simvastatin
versus simvastatin: Will the increased risk of cancer make ezetimibe/simvastatin an inappropriate
treatment choice?” (Poster Presentation). International Society for PharmacoEconomics and
Outcomes Research, Orlando, Florida, 16-20 May 2009.
16. *Pei-Jung Lin, Andrea K. Biddle, Matthew L. Maciejewski. “Racial disparities in antidementia
medication, antidepressant and antipsychotic use among Medicare beneficiaries with Alzheimer’s
Disease and related dementias”. (Oral Presentation). International Society for PharmacoEconomics
and Outcomes Research, Orlando, Florida, 16-20 May 2009.
17. *Elizabeth Li-Jung Ku, Andrea K. Biddle. “The cost-effectiveness of glucosamine sulfate treatment
among elderly knee osteoarthritis patients”. (Poster Presentation). 7th World Congress of Health
Economics, Beijing , China, 12-15 July 2009.
18. *Pei-Jung Lin, Andrea K. Biddle, Matthew L. Maciejewski. “Who has Alzheimer’s Disease?
Identifying community-dwelling Alzheimer’s patients from observational data”. (Poster
Presentation). International Conference On Alzheimer’s Disease, Chicago, IL, 26-31 July 2008.
19. *Jesse C. Lichstein, Andrea K. Biddle, John C. Lavelle. “Cost-utility analysis of sacral nerve
stimulation and botulinum-A for the treatment of urinary urge incontinence in women 65 and older”.
(Poster Presentation). International Consultation on Incontinence, Paris, France, 5-8 July 2008.
20. *Pei-Jung Lin, Andrea K. Biddle, Matthew L. Maciejewski. “The concentration and persistence of
health care expenditures and prescription drug expenditures among Medicare beneficiaries with
Alzheimer’s Disease”. (Poster Presentation). International Society for PharmacoEconomics and
Outcomes Research, Toronto, Ontario, Canada, 2-5 May 2008.
Updated: May 29, 2014 -10-
21. †Patrick Ryan, Andrea K. Biddle. “Cost-effectiveness of proton pump inhibitors for patients with
gastroesophageal reflux disease: Should emerging safety concerns affect therapeutic decision-
making?” (Poster Presentation). Toronto, Ontario, Canada, 2-5 May 2008. (Finalist ISPOR best
poster award)
22. *Stephanie B. Wheeler, Andrea K. Biddle. “Comparative cost-effectiveness of reversible family
planning methods in a Medicaid population?” (Poster Presentation). 9th Annual Women’s Health
Research Conference, University of North Carolina at Chapel Hill, 1-2 April 2008.
23. †Sylvia I. Becker-Dreps, Andrea K. Biddle, Audrey E. Pettifor, Gertrude Musuamba, David Nku
Imbie, Vera Melotte, Steven R. Meshnick, Frieda Behets. “Cost-effectiveness of adding bednet
distribution for malaria prevention to a vertical HIV transmission prevention program”. (Oral
Presentation). Triangle Malaria Symposium, Duke University Center for Global Health, Durham, NC
15 November 2007.
24. †Sylvia I. Becker-Dreps, Andrea K. Biddle, Audrey E. Pettifor, Gertrude Musuamba, David Nku
Imbie, Vera Melotte, Steven R. Meshnick, Frieda Behets. “Cost-effectiveness of adding bednet
distribution for malaria prevention to a vertical HIV transmission prevention program.” (Poster
Presentation). American Society of Tropical Medicine and Hygiene, Philadelphia, PA, 4-8 November
2007.
25. *Manabu Akazawa, Sally C. Stearns, Andrea K. Biddle. “Impact of early initiation of inhaled
corticosteroids on resource utilization and costs in patients with COPD: A propensity score matching
approach”. (Oral Presentation). International Society for PharmacoEconomics and Outcomes
Research, Arlington, VA, 21 May 2007.
26. *Manabu Akazawa, Sally C. Stearns, Andrea K. Biddle. “Assessing treatment effects of inhaled
corticosteroid on medical costs among COPD patients: Longitudinal analysis of managed care
claims”. (Poster Presentation). International Society For Pharmacoeconomics And Outcomes
Research, Arlington, VA, 22 May 2007.
27. †Shih-Yen Sharon Chen, Pei-Jung Paige Lin, Andrea K. Biddle. “Cost-utility analysis of tegaserod
for the treatment of Irritable Bowel Syndrome”. International Society for Pharmacoeconomics and
Outcomes Research annual meeting, Philadelphia, PA, 20-24 May 2006. Received Honorable
Mention for Best Poster Presentation.
28. Kit N. Simpson, Andrea K. Biddle, Peter J. Leone, Christopher D. Pilcher. “Cost effectiveness of
screening for acute HIV-infection in a sexually transmitted disease clinic setting: The North Carolina
STAT Program”. (Oral Presentation). 13th Annual Retrovirus Conference, Denver, CO, 5-9 February
2006.
29. Laura Linnan, Veronica Carlisle, Alice Ammerman, Kant Bangdiwala, Kelly Evenson, Andrea K.
Biddle. “Recruiting beauty salons, licensed stylists, and their customers: Results from the North
Carolina BEAUTY and Health Project”. (Roundtable Presentation). American Public Health
Association, New Orleans, LA, 5-9 November 2005 (actually presented in December 2005 due to
Hurricane Katrina).
30. Kit N. Simpson, Andrea K. Biddle, Peter J. Leone, Christopher D. Pilcher. “Cost effectiveness of
screening for acute HIV-infection in a sexually transmitted disease clinic setting: The North Carolina
STAT Program”. (Oral Presentation). 13th Annual Retrovirus Conference, Denver, CO, 5-9 February
2006.
31. Laura Linnan, Veronica Carlisle, Alice Ammerman, Kant Bangdiwala, Kelly Evenson, Andrea K.
Biddle. “Recruiting beauty salons, licensed stylists, and their customers: Results from the North
Carolina BEAUTY and Health Project”. (Roundtable Presentation). American Public Health
Association, New Orleans, LA, 5-9 November 2005 (actually presented in December 2005 due to
Hurricane Katrina).
32. *Rachel L. DiSantostefano, Andrea K. Biddle, John K. Lavelle. “Cost-effectiveness analysis of
benign prostatic hyperplasia treatments”. (Poster Presentation). Urological Association Annual
Meeting, San Antonio, TX, 21-26 May 2005. (Lavelle made presentation for DiSantostefano during
maternity leave)
33. *Rachel L. DiSantostefano, Andrea K. Biddle, John K. Lavelle. “Cost-effectiveness analysis of
benign prostatic hyperplasia treatments”. (Poster Presentation). International Society for
Updated: May 29, 2014 -11-
Pharmacoeconomics and Outcomes Research Annual Meeting, Alexandria, VA, 15-18 May 2005
(Biddle made presentation for DiSantostefano during maternity leave), received Honorable Mention
for Best Poster Presentation.
34. Laura Linnan, Veronica Carlisle, Alice Ammerman, Kant Bangdiwala, Kelly Evenson, Andrea K.
Biddle. “Organizational level recruitment: Results of the North Carolina BEAUTY and Health
Project”. (Oral Presentation). Society of Behavioral Medicine Annual Meeting, Boston, MA, 17
April 2005.
35. Andrea K. Biddle. “Selected issues for Markov modeling”. (Oral Presentation). 2004 Worldwide
Outcomes Research Forum, New York, NY, 21 April 2004.
36. *Andrea K. Biddle, Rachael L. DiSantostefano. “Designing cost-effectiveness analyses: A primer”.
(Workshop). 2003 Annual Meeting of the Nursing Annual Research Conference, Chapel Hill, NC, 8
October 2003.
37. *Rui G. Portugal-Fernandes, Andrea K. Biddle. “A study of cost-effectiveness analysis of the
varicella vaccine in Portugal”. (Poster Presentation). 6th European Meeting of the International
Society for Pharmacoeconomics and Outcomes Research, Barcelona, Spain, 10-11 November 2003.
38. *Rachael L. DiSantostefano, Andrea K. Biddle. “Cost-effectiveness of pharmacotherapy in treating
men with moderate to severe symptomatic benign prostatic hyperplasia”. (Oral Presentation). 2003
Annual Meeting of the International Society for Technology Assessment in Health Care, Canmore,
Alberta, Canada, 24 June 2003.
39. †Kara L. Suter, Andrea K. Biddle. “Bupropion Sr versus sertraline in the treatment of late-life
depression: Which is more cost-effective?” (Poster Presentation). 2003 Annual Meeting of the
International Society for Technology Assessment in Health Care, Canmore, Alberta, Canada, 23 June
2003.
40. *Scott R. Stewart, Andrea K Biddle, Will Dow. “Preventing vertical HIV transmission in Africa: the
effect of model specification in cost-effectiveness analysis”. (Oral Presentation). 4th World
Congress of the International Health Economics Association, San Francisco, CA, 15-18 June 2003.
41. †Kara L. Suter, Andrea K. Biddle. “The cost-utility of bupropion Sr versus sertraline in the treatment
of late-life depression”. (Poster Presentation). 8th Annual International Meeting of the International
Society for Pharmacoeconomics and Outcomes Research, Crystal City, VA, 20 May 2003.
42. Andrea K. Biddle. “Choosing Healthplans All Together: Consumer preferences and priorities for
health benefits”. (Oral Presentation). Pharmaceutical Policy Summit, Washington, DC, 21-22
January 2003.
43. Andrea K. Biddle, Linda R. Watson, Celia R. Hooper. “Using evidence-based research in speech-
language pathology”. (Oral Presentation). Academy of Neurological Communication Disorders and
Science Meeting, Atlanta, GA, 20 November 2002.
44. Andrea K. Biddle, Linda R. Watson, Celia R. Hooper. “Using evidence-based research in speech-
language pathology”. (Oral Presentation). American Speech-Language-Hearing Association
Meeting, Atlanta, GA, 24 November 2002.
45. Andrea K. Biddle, Linda R. Watson, Celia R. Hooper. “Using Evidence-based research in the school
setting: A primer”. (Workshop presented twice). National Black Association of Speech-Language
and Hearing Meeting, Raleigh, NC, 13 April 2002.
46. *Winghan Jacqueline Kwong, Andrea K. Biddle, Ya-Chen Tina Shih. “Cost benefit analysis of
sumatriptan tablets versus usual non-triptan therapy for the treatment of migraine”. (Poster
Presentation). 11th International Headache Research Seminar, Copenhagen, Denmark, 30 November
2001.
47. †Wendy Johnson-Taylor, Andrea K. Biddle, Pamela Haines, Charles van der Horst, Janice R. Dodd,
Boyd Switzer. “Impact of nutrition intervention for patients with AIDS-related wasting on health
related quality of life”. (Poster Presentation). American Public Health Association Meeting, Atlanta,
GA, 23 October 2001.
48. †Wendy Johnson-Taylor, Janice R. Dodd, Pamela Haines, Charles van der Horst, Boyd Switzer,
Andrea K. Biddle. “Impact of medical nutrition intervention therapy on nutritional indices of patients
with AIDS-related wasting”. (Poster Presentation). American Public Health Association Meeting,
Atlanta, GA, 23 October 2001.
Updated: May 29, 2014 -12-
49. Susan Dorr Goold, Andrea K. Biddle, Ellen Benavides, Marion Danis “Will uninsured Minnesotans
give up benefit coverage to include the uninsured?” (Poster Presentation). Society for General
Internal Medicine, San Diego, CA, 2-5 May 2001.
50. Susan Dorr Goold, Andrea K. Biddle, Glenn Klipp, Marion Danis. “Choosing Healthplans All
Together A game to assess consumer values and preferences for health insurance”. (Oral
Presentation). Third International Conference on Priorities in Health Care, Amsterdam, the
Netherlands, 23-24 November 2000.
51. Marion Danis, Andrea K. Biddle, Susan Dorr Goold. “Health insurance priorities of patient groups”.
(Oral Presentation). Third International Conference on Priorities in Health Care, Amsterdam, the
Netherlands, 23-24 November 2000.
52. Andrea K. Biddle, Susan Dorr Goold, Glenn Klipp, Marion Danis. “Choosing Healthplans All
Together A game to assess public values and preferences for health insurance”. (Oral Presentation).
American Public Health Association, Boston, MA, 14 November 2000.
53. †Birgitta von Scheele, Andrea K. Biddle. “A cost-effectiveness analysis of upgrading maternal health
care in a developing country”. (Oral Presentation). American Public Health Association, Boston,
MA, 14 November 2000.
54. *Zhimei Liu, Lin-Feng Xu, Andrea K. Biddle, Gordon G. Liu. “Cost-effectiveness analysis of the
self-management plane versus traditional treatment plan for adults patients with chronic asthma”.
(Oral presentation). American Public Health Association, Boston, MA, 15 November 2000.
55. †Maryam Navaie-Waliser, Andrea K. Biddle, Sandra L. Martin. “Methodological issues in studying
the impact and cost-effectiveness of care coordination services”. (Co-presented Oral Presentation).
2nd Annual Meeting of Child Health Services Researchers, Los Angeles, CA, 27 June 2000.
56. Andrea K. Biddle, Susan Dorr Goold, Marion Danis. “Defining a benefit package for the uninsured”.
(Poster Presentation). Association for Health Services Research Annual Meeting, Los Angeles, CA,
26 June 2000.
57. †Maryam Navaie-Waliser, Andrea K. Biddle, Sandra L. Martin. “The impact and cost-effectiveness
of care coordination services relative to infant survival”. (Oral Presentation). Association for Health
Services Research Annual Meeting, Los Angeles, CA, 26 June 2000.
58. Susan Dorr Goold, Andrea K. Biddle, Marion Danis “Choosing Healthplans All Together A game to
assess consumer values and preferences for health insurance”. (Poster Presentation). Association for
Health Services Research Annual Meeting, Los Angeles, CA, 25-27 June 2000.
59. *W. Jackie Kwong, Andrea K. Biddle, Ya-Chen Tina Shih, Teresa L. Kauf. “Cost-benefit analysis
of sumatriptan tablets versus usual therapy for the treatment of migraine”. (Poster Presentation).
American Headache Society Annual Scientific Meeting, Montreal, Quebec, Canada, 23-25 June 2000.
60. †Yu-Chen Yeh, Andrea K. Biddle, Abraham G. Hartzema. “Cost-effectiveness analysis of lamivudine
treatment in chronic Hepatitis B”. (Poster Presentation). International Society for
Pharmacoeconomics and Outcomes Research, Arlington, VA, 21-24 May 2000.
61. Susan Dorr Goold, Andrea K. Biddle, Glenn Klipp, Marion Danis. “Choosing Healthplans All
Together: A game to assess consumer values and preferences for health insurance”. (Poster
Presentation). Society for General Internal Medicine Annual Meeting, Boston, MA, 4-6 May 2000.
62. Marion Danis, Andrea K. Biddle, Susan Dorr Goold. “Insurance preferences of the uninsured”.
(Poster Presentation). Society for General Internal Medicine Annual Meeting, Boston, MA, 4-6 May
2000.
63. †Kathryn Andersen Clark, Andrea K. Biddle, Sandra L. Martin. “A cost-benefit analysis of the
Violence Against Women Act of 1994”. (Oral Presentation). American Public Health Association
Annual Meeting, Chicago, Illinois, 7-11 November 1999.
64. *Brian C. Castrucci, Andrea K. Biddle. “Predictors of cost related to inpatient pediatric asthma
treatment”. (Poster Presentation). American Public Health Association Annual Meeting, 7-11
November 1999.
65. *Joanna E. Cohen, R. Gary Rozier, Adam O. Goldstein, Andrea K. Biddle, Michael Munger, Nancy
Milio. “Getting right down to it: The relation between legislators’ ideology and their support of
tobacco control policies”. (Oral Presentation). American Public Health Association Annual Meeting,
Chicago, Illinois, 7-11 November 1999.
Updated: May 29, 2014 -13-
66. †Maryam Navaie-Waliser, Andrea K. Biddle, Sandra L. Martin. “The impact and cost-effectiveness
of care coordination services relative to the survival of Medicaid-eligible infants in North Carolina”.
(Poster Presentation). American Public Health Association Annual Meeting, Chicago, Illinois, 7-11
November 1999.
67. *Andrea K. Biddle, Liana M. DesHarnais. “Adding rigor to the guideline development process: The
methodologist’s responsibility”. (Oral Presentation). American Paraplegia Society Annual Meeting,
Las Vegas, Nevada, 9 September 1999.
68. Andrea K. Biddle, Kit N. Simpson. “A Comparison of the sensitivity and robustness of generic and
disease-specific health-related quality of life instruments in children with seasonal allergic rhinitis”.
(Oral Presentation). Annual Meeting of the International Society of Technology Assessment in Health
Care, Edinburgh, Scotland, 23 June 1999.
69. Ya-Chen Tina Shih, Andrea K. Biddle, Michael T. Halpern. “Pharmacoeconomics of screening and
testing”. (Methods Workshop) Annual Meeting of the International Society for Pharmacoeconomics
and Outcomes Research, Washington, DC, 25 May 1999.
70. Andrea K. Biddle, Kit N. Simpson. “Modelling the use of triple combination therapy in five
countries: Nevirapine, zidovudine, and didanosine”. (Poster Presentation). 4th International
Congress on Drug Therapy in HIV Infection, Glasgow, Scotland, 8-12 November 1998.
71. Andrea K. Biddle, Kit N. Simpson. “Modelling the use of nevirapine triple combination therapy in
the United Kingdom: An economic evaluation”. (Poster Presentation). 4th International Congress
on Drug Therapy in HIV Infection, Glasgow, Scotland, 8-12 November 1998.
72. *Laurie J. Goldsmith, Andrea K. Biddle, Robert S. Brown, Jr. “Cost-effectiveness analysis of
prophylactic therapies for CMV disease after liver transplantation”. (Poster Presentation). American
Association for the Study of Liver Diseases Annual Meeting, New Orleans, Louisiana, 4-6 November
1998.
73. Andrea K. Biddle, Erin P. Fraher. “Living in an evidence-based world: On what do you base your
standards? A primer on evidence-based practice”. (Oral Presentation). Council on Licensure,
Enforcement and Regulation Annual Meeting, Denver, Colorado, 19 September 1998.
74. Rebecca Slifkin, Victoria Freeman, Andrea K. Biddle, Kate Faherty, Dee Musselman, Priscilla Guild,
Gordon DeFriese. “The cost of immunization registries: Four case studies”. (Oral Presentation). All
Kids Count Annual Registry Conference, New Orleans, Louisiana, April, 1998.
75. Rebecca Slifkin, Victoria Freeman, Andrea K. Biddle, Kate Faherty, Dee Musselman, Priscilla Guild,
Gordon DeFriese. “Assessing the costs of childhood immunization registries”. (Oral Presentation).
American Public Health Association Annual Meeting, Indianapolis, Indiana, November, 1997.
76. Mark W. Russo, Andrea K. Biddle, Robert S. Sandler. “Serial fecal occult blood testing detects more
cancers at a lower cost”. (Poster Presentation). American Gastroenterological Association Annual
Meeting, 12-14 May 1997.
77. Andrea K. Biddle, Kit N. Simpson, Susan A. Fiscus. “Current practice vs. mandatory prenatal HIV
testing: Cost and outcomes based on North Carolina data”. (Poster Presentation). 4th Conference on
Retroviruses and Opportunistic Infections, Washington, D.C., 22-26 January 1997.
78. Andrea K. Biddle, Marion Danis, Gail Henderson, Joanne M. Garrett, Robert F. DeVellis. “Insurance
coverage preferences: What do Medicare enrollees choose?” (Poster Presentation). Association for
Health Services Research Annual Meeting, Atlanta, Georgia, 9-11 June 1996.
79. †Andrea K. Biddle, Carol Rapaport, Christopher A. Trenholm. “Winners and losers: Trends in
outpatient expenditures, 1977 and 1987”. (Poster Presentation). Association for Health Services
Research Annual Meeting, Chicago, Illinois, 4-6 June 1995.
80. *Andrea K. Biddle, Carol Rapaport, Nancy D. Berkman. “Medicaid (1977-1987): An effective safety
net for whom?” (Poster Presentation). Association for Health Services Research Annual Meeting,
Chicago, Illinois, 4-6 June 1995.
81. *Andrea K. Biddle, Carol Rapaport, Nancy D. Berkman, Noah D. Glick, Kenneth E. Thorpe. “The
increase in the uninsured (1977-1987): Disentangling the effects of demographic and structural
shifts”. (Poster Presentation). Association for Health Services Research Annual Meeting, San Diego,
California, 12 June 1994.
Updated: May 29, 2014 -14-
82. *Julie C. Jacobson, Andrea K. Biddle, George Mercer, Sara Chaffee, Charles Daeschner, Andrew
Olshan, Stuart Gold. “Health insurance denials of long-term survivors of childhood cancer in North
Carolina”. (Oral Presentation). 3rd
International Conference on Long-Term Complications of
Treatment of Children and Adolescents for Cancer, Niagara Falls, New York, 10-11 June 1994.
83. Andrea K. Biddle, Kit N. Simpson, N. Regina Rabinovich. “A model for estimating the impact of
research investment choices for pertussis vaccine”. (Oral Presentation). Association for Public
Policy and Management Annual Meeting, Denver, Colorado, 30 October 1992.
84. Andrea K. Biddle, Kit N. Simpson, N. Regina Rabinovich. “A model for estimating the impact of
research investment choices on the Children’s Vaccine Initiative”. (Poster Presentation). Association
for Health Services Research Annual Meeting, Chicago, Illinois, 7 June 1992.
85. Gerald F. Kominski, Andrea K. Biddle. “Changes in follow-up care for Medicare surgical patients
under PPS”. (Oral Presentation). American Public Health Association Annual Meeting, Atlanta,
Georgia, 11 November 1991.
86. Andrea K. Biddle. “Financing AIDS: Ethical and practical considerations”. (Oral Presentation).
Pew Health Policy Conference, Boston, Massachusetts, 28 May 1987.
87. Andrea K. Biddle. “The economic impact of increasing safety belt use in Texas”. (Oral
Presentation). Presented at the Association for the Social Sciences in Health, American Public Health
Association Annual Meeting, Las Vegas, Nevada, 29 September 1986.
OTHER UN-REFEREED WORKS (* Indicates Health Policy and Management student, † Indicates other student)
Technical Research Reports for Agencies, Institutes, and Centers:
1. Andrea K. Biddle, Linda R. Watson, Celia R. Hooper, Kathleen N. Lohr, Sonya F. Sutton. Final
Evidence Report for Criteria for Determining Disability in Speech and Language Disorders.
Submitted to the Agency for Healthcare Research and Quality and the Social Security Administration,
26 November 2001.
2. Andrea K. Biddle, Linda R. Watson, Celia R. Hooper, Kathleen N. Lohr. Draft Evidence Report for
Criteria for Determining Disability in Speech and Language Disorders. Submitted to the Agency for
Healthcare Research and Quality and the Social Security Administration, 23 August 2001.
3. Ellen Benavides, Andrea K. Biddle. Minnesota CHAT (Choosing Healthplans All Together). Allina
Medical Foundation, Minneapolis, MN, October 2000.
4. *Andrea K. Biddle, Tamara Dempsey-Tanner, the UNC Methodological Team. The Acute
Management of Autonomic Dysreflexia: Results of Literature Search and Evidence Analysis. Final
Report. Paralyzed Veterans of America, July 1999.
5. *Andrea K. Biddle, Erin P. Fraher, the UNC Methodological Team. Pressure Ulcer Prevention and
Management Clinical Practice Guideline: Results of Literature Search and Evidence Analysis. Final
Report. Paralyzed Veterans of America, September 1998.
6. *Andrea K. Biddle, Erin P. Fraher, the UNC Methodological Team. Functional Outcomes
Management Clinical Practice Guideline: Results of Literature Search and Evidence Analysis. Final
Report. Paralyzed Veterans of America, September 1998.
7. Andrea K. Biddle, Kit N. Simpson. Estimates of the Short-Term Cost Offset and Cost-Effectiveness of
Adding Nevirapine to Zidovudine and Didanosine Double Combination Therapy in Canada.
Confidential Client, August 1998.
8. Rebecca T. Slifkin, Victoria A. Freeman, Andrea K. Biddle, Kate M. Faherty, Priscilla A. Guild, Dee
A. Musselman, Gordon H. DeFriese. The Cost of Immunization Registries: Four Case Studies. The
Robert Wood Johnson Foundation, April 1998.
9. Andrea K. Biddle, Kit N. Simpson. Estimates of the Short-Term Cost Offset and Cost-Effectiveness of
Adding Nevirapine to Zidovudine and Didanosine Double Combination Therapy in Five Countries.
Confidential Client, April 1998.
Updated: May 29, 2014 -15-
10. Andrea K. Biddle, Kit N. Simpson. Estimates of the Short-Term Cost Offset and Cost-Effectiveness
of Adding Nevirapine to Zidovudine and Didanosine Double Combination Therapy in the United
Kingdom. Confidential Client, April 1998.
11. Andrea K. Biddle, Kit N. Simpson. Estimates of the Short-Term Cost Offset and Cost-Effectiveness
of Adding Nevirapine to Zidovudine and Didanosine Double Combination Therapy in the United
States. Confidential Client, April 1998.
12. *Andrea K. Biddle, Erin P. Fraher, the UNC Methodological Team. Neurogenic Bowel Management
in Adults with Spinal Cord Injury: Results of Literature Search and Evidence Analysis. Final Report.
Paralyzed Veterans of America, March 1998.
13. Andrea K. Biddle, Kit N. Simpson. Estimates of the Short-Term Cost Offset and Cost-Effectiveness
of Adding Nevirapine to Zidovudine and Didanosine Double Combination Therapy in Italy.
Confidential Client, February 1998.
14. Andrea K. Biddle, Kit N. Simpson. Estimates of the Short-Term Cost Offset and Cost-Effectiveness
of Adding Nevirapine to Zidovudine and Didanosine Double Combination Therapy in Spain.
Confidential Client, February 1998.
15. *Andrea K. Biddle, Noah D. Glick, Nancy D. Berkman, Carol Rapaport, Bruce L. Allen. Analyzing
Changes in the Uninsured: Estimating the Effect of Changes in Family Structure and Employment
Patterns. Preliminary Insurance Analyses. The Commonwealth Fund, Grant No. 93-32, January
1994.
16. *Andrea K. Biddle, Jane D. Pitcher. Evaluation of the Advocare Program Parts A and B. American
Foundation for AIDS Research. Subcontract from the Lesbian and Gay Health Project and the AIDS
Service Agency of Wake County, December 1993.
17. *Andrea K. Biddle, Noah D. Glick, Nancy D. Berkman, Carol Rapaport, Bruce L. Allen. Analyzing
Changes in the Uninsured: Estimating the Effect of Changes in Family Structure and Employment
Patterns. Descriptive Analyses. The Commonwealth Fund, Grant No. 93-32, September 1993.
18. Kit N. Simpson, Andrea K. Biddle. A Model for Estimating the Impact of Research Investment
Choices for the Children's Vaccine Initiative. Final Report-Phase II. National Institute of Health,
Order No. 263-MD-14293, 1993.
19. Kit N. Simpson, Andrea K. Biddle, Duncan P. Boldy. A Model for Estimating the Impact of Research
Investment Choices for the Children's Vaccine Initiative. Final Report-Phase I. National Institute of
Health, Order No. 263-MD-14293, 1993.
20. Gerald F. Kominski, Andrea K. Biddle. Changes in Follow-up Care for Medicare Surgical Patients
Under the Prospective Payment System, RAND, R-4106-HCFA, 1992.
21. Andrea K. Biddle Public Health, Privacy, and Politics: HIV Partner Notification, The RAND
Corporation, N-3244-RC, April 1991.
22. Gerald F. Kominski, Andrea K. Biddle, Christina J. Witsberger. Changes in Follow-up Care for
Medicare Surgical Patients Under PPS, The RAND Corporation, WD-5149-HCFA, October 1990.
23. Andrea K. Biddle, Grace M. Carter, John S. Uebersax, John D. Winkler. The Research Careers of
RSA/RSDA Recipients, The RAND Corporation, R-3688-NIMH, 1988.
24. Andrea K. Biddle. An Annotated Guide to Occupant Protection Activities, Materials, and
Programs-Part I: A Guide for State and Local Health Agencies in the United States, U.S.
Government Printing Office, Washington, DC, September 1987.
25. Andrea K. Biddle. An Annotated Guide to Occupant Protection Activities, Materials, and Programs
in Texas-Part II: A Guide for State and Local Health Agencies, U.S. Government Printing Office,
Washington, DC, September 1987.
26. Grace M. Carter, John D. Winkler, Andrea K. Biddle. An Evaluation of the NIH Research Career
Development Award, The RAND Corporation, R-3568-NIH, 1987.
Bulletins and Newsletters:
1. Andrea K. Biddle. “Developing occupant protection programs”. Health Education Focal Points
1986;3:9-10.
Updated: May 29, 2014 -16-
2. Andrea K. Biddle. “Occupant protection legislative activity: Current status”. Health Education
Focal Points 1986;1:11-14.
TEACHING RECORD
COURSES TAUGHT IN PAST THREE YEARS (2011-2014)
Semester Course Enrollment
University of North Carolina at Chapel Hill
Spring 2014 HPM 785 Advanced Decision Modeling 12 (+2 auditors)
Fall 2013 HPM 772 (Techniques for the Economic Evaluation of Health Care
Technologies)
28 (+2 auditors)
Fall 2013 HPM 884 (Health Services Research Methods I) 14
Spring 2013 HPM 890, Section 002 Advanced Decision Modeling 5
Fall 2012 HPM 772 (Techniques for the Economic Evaluation of Health Care
Technologies)
26 (+1 auditor)
Fall 2012 HPM 884 (Health Services Research Methods I) 13
Fall 2011 HPM 772 (Policy Analysis and Technology Assessment) 27 (+2 auditors)
Fall 2011 HPM 870 (Doctoral Seminar in Health Policy and Management II) 10 (+1 auditor)
Fall 2011 MHCH 740 (Doctoral Seminar in Maternal and Child Health 7
GUEST LECTURES
Department of Health Policy and Management:
1. “Preparing Poster Presentations for Conferences”. Lecture for HPM 692H: Independent Honors
Research (Karl Umble). Spring 2012
2. “Medical Technology”. Lecture for HPM 350: Introduction to Health Services Systems (Melanie
Studer), Fall 2011.
3. “Preparing Poster Presentations for Conferences”. Lecture for HPM 692H: Independent Honors
Research (Chris Shea), Spring 2011.
4. “Using Economic Evaluation in Comparative Effectiveness Research”. Lecture for HPM 496:
Comparative Effectiveness Seminar, Spring 2011.
5. “Technology Assessment and Economic Evaluation”. Lecture for HPM 496: Comparative
Effectiveness Seminar, Spring 2011.
6. “Research from the Decision Scientist’s Perspective”. Lecture for HPM 874: Research Policy
Seminar in Health Policy and Administration), Lecture for HPAA 873: Research Policy Seminar in
Health Policy and Management, Fall 2010.
7. “Female Sexual Function: Effects on Quality of Life”. Lecture for HPM 873: Research Policy
Seminar in Health Policy and Administration, Spring 2010.
8. “The Cost-Effectiveness of Adding Bed net Distribution for Malaria Prevention to Antenatal Clinics
in Kinshasa, DRC”. Lecture for HPM 873: Research Policy Seminar in Health Policy and
Administration, Fall 2007.
9. “Ethics and Surviving the IRB Submission Process”. Lecture for HPAA 953: Dissertation Planning
and Preparation, Summer II 2007.
10. “The Humanistic Burden of HSDD: More than just Sex”. Lecture for HPAA 873: Research Policy
Seminar in Health Policy and Administration), Fall 2006.
Updated: May 29, 2014 -17-
11. “Ethics and Surviving the IRB Submission Process”. Lecture for HPAA 353: Dissertation Planning
and Preparation, Summer II, 2006.
12. “Preparing Posters for Scientific Conferences”. Lecture for HPAA 361: Doctoral Seminar in Health
Policy and Administration, Spring, 2006
13. “Families Ties: The Cost-Effectiveness of Smoking Cessation for Lung Cancer Patient Families”.
Lecture for HPAA 360: Policy Seminar in Health Policy and Administration (HPAA Doctoral
Research Seminar), Fall, 2005
14. “Families Ties: The Cost-Effectiveness of Smoking Cessation for Lung Cancer Patient Families”.
HPAA 360: Policy Seminar in Health Policy and Administration, Fall/Spring 2005.
15. “Technology Assessment in Health Care”. HPAA 220: Evolution and Financing of the US Health
Care System, Fall 2002.
16. “Technology Assessment in Health Care”. HPAA 220: Evolution and Financing of the US Health
Care System, Fall 2001.
17. “Technology Assessment in Health Care”. HPAA 220: Evolution and Financing of the US Health
Care System, Fall 1998.
18. “Clinical Practice Guidelines: Issues in Development and Implementation”. HPAA 107: Theory and
Practice of Public Health Policy and Administration, Summer 1998.
19. “Clinical Practice Guidelines: Development Issues”. HPAA 301: Doctoral Seminar in Health Policy
and Administration II, Spring 1996.
20. “The Role of Insurance in Health Care Delivery in the United States”. HPAA 220: Evolution,
Organization, and Financing of the U.S. Health System. Executive Program in Health and Population
for Developing Countries, Summer 1995.
21. “Effect of Insurance on Health Care Delivery in the United States”. HPAA 220: Evolution,
Organization, and Financing of the U.S. Health System. Executive Program in Health and Population
for Developing Countries, Summer 1994.
22. “Financing Health Care in the United States”. HPAA 70: Introduction to Health Services Systems,
Fall 1992.
23. “Hospital Rate-Setting Approaches”. HPAA 279: Competition, Regulation, and Financing, Fall
1992.
24. “Economic Evaluation in Clinical Research”. Lecture for EPID 690: Problems in Epidemiology:
Design of Clinical Research, Spring 2011.
UNC-Chapel Hill and Other Institutions:
1. “Introduction to Economic Evaluation”. Lecture for MHCH 723: Introduction to Monitoring &
Evaluation (Ilene Speizer), 2 lectures, Fall 2008.
2. “Economic Analysis for Infectious Diseases”. Lecture for EPID 752: Infectious Disease
Epidemiology, Fall 2007.
3. “Economic Analysis for Infectious Diseases”. Lecture for EPID 752: Infectious Disease
Epidemiology, Fall 2006.
4. “Decision Analysis”. Lecture for HBHE/PUBH 201: Communication for Health-related
Decisionmaking, Spring 2006
5. “Costing and Cost of Illness”. MHCH 140 (Sec. 013): Economic Evaluation of Children’s Programs,
Spring 2006.
6. “Ethics and Surviving the IRB Submission Process”. MHCH 315: Program Assessment in Maternal
and Child Health, Spring 2006.
7. “Humanizing the IRB”. EPID 210: Foundations in Public Health Ethics, October 27, 2005.
8. “Health-Related Quality of Life (HRQoL) and Utilities”. NRSA Pre- and Post-Doctoral Seminar,
Cecil G. Sheps Center for Health Services Research, Spring 2005.
9. Topic: “Designing Cost-Effectiveness Analyses: A Primer”. EPID212: Epidemiology of Medical
Care , Fall 2004.
10. “Cost of Violence Against Women and the Evaluation of these Costs”. MHCH 253/HBHE 140:
Violence Against Women: A Public Health Perspective, Spring 2004.
Updated: May 29, 2014 -18-
11. “Cost-Effectiveness of Bicycle Helmets in Preventing Injury and Death”. UNC Preventive Medicine
Fellows, October 29, 2003.
12. “RxEconomics and RxEpidemiology: Why We Need Each Other”. EPID 232:
Pharmacoepidemiology, Fall 2002.
13. Topic: “Modeling and Meta-Analysis”. EPID301/PPES362: Pharmacoepidemiology Seminar,
School of Pharmacy/School of Public Health, UNC-Chapel Hill, Spring 2002.
14. “Designing Costs Analyses”. NURS337: Designing Intervention Studies, School of Nursing, UNC-
Chapel Hill, Spring 2000.
15. “Economic Analysis for Health Care Technologies”. Robert Wood Johnson Clinical Scholars
Program, School of Medicine, UNC-Chapel Hill, Spring 2000.
16. “Cost-Benefit Analysis”. 1999 Summer Institute for Legislative Health Staff Development:
Understanding the Fundamentals of State Health Policy, UNC-Chapel Hill, Summer II 1999.
17. “Economic Analysis for Health Care Technologies”. Robert Wood Johnson Clinical Scholars
Program, School of Medicine, UNC-Chapel Hill, Spring 1999.
18. “Cost-Effectiveness Analysis in Prevention”. PUBH 250: Strategies for Prevention for Clinicians,
Schools of Medicine and Public Health, UNC-Chapel Hill, Fall 1998.
19. “Developing Research Proposals”. PUBH 395: Dissertation Seminar, Public Health Leadership
Program, UNC-Chapel Hill, Spring 1996.
20. “The Gucci Set: The Influence of Special Interests on Health Politics”. School of Dentistry, UNC-
Chapel Hill, Fall 1994.
21. “Cost-Effectiveness and Cost-Benefit Analyses”. Department of Health Behavior and Health
Education, School of Public Health, UNC-Chapel Hill, Fall 1993.
22. “Financing the Costs of AIDS and HIV Disease”. AIDS Symposium, Campbell University, Buies
Creek, North Carolina, 6 April 1993.
23. “CBA/CEA Methods for Primary Care Researchers”. UNC Primary Care Research Seminar, School of
Medicine, UNC-Chapel Hill, Spring 1992.
DOCTORAL STUDENT SUPERVISION (* Indicates Health Policy and Management student, † Indicates other student)
Dissertation Chair or Primary Advisor:
1. *Jamie Jarmul (2013-present). Potential Dissertation Topic: under development.
2. *Sue Lynn Ledford (DrPH) (2013-present). “Pediatric Adult HIV Care Transition—The Individual
and Family Perspective”. Proposal defense anticipated July 2014.
3. *Todd Durham (2012-present). Potential Dissertation Topic: under development.
4. *Monica Schmidt (2011-present). “Design and Validation of a Decision Tool to Predict Post-
Surgical Mortality Amongst Patients with Liver Cirrhosis: Go or No-go to the Surgical Suite”.
Proposal defense anticipated August 2014.
5. *Ye (Julia) Zhu (2011-present). Potential Dissertation Topic: under development.
6. *Darwin Young (2010-2013). Transferred to Dr. Bruce Fried.
7. *Gina Ogilvie (DrPH) (2010-2011). Transferred to Dr. Sandra Greene.
8. *Sarah E. Rutstein (2009-present, Medical School 2011-2013). Optimizing HIV therapy:
Virological Monitoring, Adherence & Cost-effectiveness”. Final defense anticipated March 2015.
9. *Laurel J. Clayton Trantham (2008-2012). “Post-treatment Surveillance of Prostate Cancer in
Elderly Men”. 2012.
10. *Wei-Shih (Danny) Yeh (2007-2010, transfer from Edward Norton). “Influence of Cancer on
Comorbidities among Senior Prostate Cancer Survivors in the United States”. 2009.
11. *Stephanie B. Wheeler (2006-2010) “Quality in Breast Cancer Treatment: Diffusion and
Disparities”. 2010.
12. *Miaomiao Liu (2005-2009[academically ineligible]).
Updated: May 29, 2014 -19-
13. *Pei-Jung (Paige) Lin (2004-2008). “Predictive Modeling of Healthcare Costs and
Institutionalization for Medicare Beneficiaries with Alzheimer’s Disease”. 2008.
14. *Manabu Akazawa (2003-2007). “Economic Evaluation of Treating Chronic Obstructive
Pulmonary Disease: The Effects of Early Initiation of Inhaled Corticosteroids on Exacerbation Risks,
Utilization, and Costs”. 2007.
15. *Rachael DiSantostefano (2001-2005). “Evaluating Medicare Reimbursement Policies for the
Treatment of Benign Prostatic Hyperplasia”. 2005.
16. *Joanne Walker (2001-2003). “Patient and Physician Adherence to Lipid-Lowering Drug
Treatment”. Transferred to Morris Weinberger, 2003. Completed Fall 2005.
17. *Sean Candrilli (2000-2004, permanent leave 2004). Potential Dissertation Topic: “Financial
Implications of Hospital Response to Patient Insurance Status”.
18. *Anupama Ayyar Krishnan (2000-present, permanent leave 2005). “Psychometric Investigation of
the Quality of Life in Depression Scale (QLDS)”.
19. *France Priez (2000-2002). Transferred to Dr. Sally C. Stearns, September 2002.
20. *Jeremy C. Mario (2000-2002). Transferred to Dr. Marisa E. Domino, 2002.
21. *David J. Harrison (2000-present). “The Association between Obesity and Disability in Older
Middle-Aged Americans”. 2003.
22. *Elinor C. Gray Chumney. (1998-2002—on leave 2000-2001). “Analytical Approaches to Costing
for CEA: Do They Make a Difference?” 2002.
23. *Rebecca L. LaVallee. (1998-2001). “Evaluation of Three Self-Reported Quality of Life Tools for
Monitoring Outcomes in Patients with Complex Chronic Disease: An Example from HIV and AIDS”.
2001.
24. *Ronald W. LaVallee. (1998-2000, permanent medical leave September 2000). “A Comparison of
Measures of Risk Adjustment Using Insurance Claims Databases”.
25. *Laurie J. Goldsmith. (1997-2000). Transferred to Dr. Thomas C. Ricketts, May 2000.
26. *Leanne Fogelman. (1997-1998, permanent leave 1998).
27. *Brent A. Walker. (1993-1996, exceeded 8-year limit).
28. *Julie C. Jacobson. (1991-1993). “An Epidemiological Study of the Insurability of Long-Term
Survivors of Childhood Cancer in North Carolina”. 1993.
Dissertation Committee Member:
1. *Diana Chirovsky. (2011-2014). “Global Impact of Surveillance to Detect Patients with
Hepatocellular Carcinoma”. 2014.
2. *Mike Park. (2011-2013). “Impact of Social Protection Programs on Child Health and Welfare in
Ghana”. 2013.
3. *Alice K. Fortune-Greeley. (2011-2013). “Outcomes and Costs of Preoperative Breast MRIs in
Elderly Breast Cancer Patients”. 2013.
4. *Dionysios Kavalieratos. “Use of Palliative Care in Congestive Heart Failure Patients”. 2012.
5. *Daniel Belsky. “Evaluating the Comparative Effectiveness of Genomic Information in Prognostic
Screening for Complex Health Conditions: Onset, Persistence, and Severity of Obesity, Asthma, and
Alcohol Dependence”. 2012.
6. †JaHyun Kang. “Prevention for Healthcare-associated Infections in US Hospital Settings”. UNC
School of Nursing, 2012.
7. *Michaela Dinan. “The Effect of Increased PET Imagining on the Staging, Outcomes, and Health
Care Utilization of Medicare Non-Small Cell Lung Cancer Patients”. 2011.
8. *Talya Salz. “Preferences for Treatment and End-of-Life Care among Patients with Advanced Lung
Cancer”. 2008.
9. *Joanne Walker Campione. “Patient and Physician Adherence to Lipid-Lowering Drug
Treatment”. 2005.
Updated: May 29, 2014 -20-
10. *Amanda S. Niskar. “Recommendations for Information Needs in the Development of a National
Public Drinking Water Surveillance System”. Interdisciplinary Curriculum in Public Health
Leadership. 2003.
11. †Emmanuel M. Ngui. “Non-Financial Barriers and Health Care Utilization by Minority Children
and Children with Special Needs”. Department of Maternal and Child Health, 2003.
12. †Kathryn Andersen Clark. “Use of Health Services and Social Cost of Intimate Partner Violence
during Pregnancy”. Department of Maternal and Child Health, 2002.
13. *Santanu K. Datta. “Hormone Replacement Therapy: Preferences for Health States and the
Decision Regarding its Long Term Use”. 2002.
14. *Jan Devier. “Measurement of Immunization Coverage Levels among Young Children for
Assessment and Assurance of Health Objectives: An Analysis of Current Data at the State Level and
Recommendations for Future Development”. Interdisciplinary Curriculum in Public Health
Leadership. 2001.
15. †Wendy Johnson-Taylor. “The Impact of Nutrition Intervention on the Quality of Life of AIDS
Patients with Wasting”. Department of Nutrition, 2000.
16. †Maryam Navaie-Waliser. “An Evaluation of the Participants, Impacts, and Costs/Benefits of the
North Carolina Baby Love Maternal Outreach Worker Program”. Department of Maternal and Child
Health, 1999.
17. †Carlos Rojas. “Evaluation of a Multifaceted Intervention to Prevent the Transmission of American
Cutaneous Leishmaniasis in Colombia”. Department of Epidemiology, 1999.
18. *Joanna E. Cohen. “Ideology and Canadian Legislators’ Support for Tobacco Control Policies”.
1999.
19. *Jim Patrick Doherty. “Obstetric Care Services and the One Child Policy: The Economic
Consequences and Choices Pregnant Women Face in China”. 1998.
20. *Robbin F. Itzler. “Outcomes and Costs of Acyclovir Prophylaxis for Herpes Simplex in Leukemia
Patients: A Triangulation of Methods to Evaluate Treatment Effectiveness”. 1998.
21. *Deborah A. Marshall. “Efficacy and Effectiveness of Combination Antiretroviral Therapies in
HIV+ Disease”. 1998.
22. *Margaret Lynn McQueen. “Interest in Evidence: Politicians’ Involvement in Developing
Evidence-Based Policies”. Interdisciplinary Curriculum in Public Health Leadership. 1998.
23. *Nancy D. Berkman. “Married Women’s Employment Choice and Access to Health Insurance
Fringe Benefits”. 1997.
24. *Carrie Nichol Klabunde. “Primary Care Physician Adoption of the National Cancer Institute
Statement of Evidence on Breast Cancer Screening: The Case of North Carolina”. 1996.
25. *Richard C. Holmes. “On the Determination of Reimbursement of Costs in the Provision of
Medicaid Services by Local Health Departments”. 1993.
26. *Jeanne M. Lambrew. “The Use of the Institute of Medicine’s Measures to Assess the Effect of
Having a Regular Doctor and Waiting Time on Access to Health Care”. 1993.
Doctoral Curriculum Committees:
1. Yi-Ting “Zoey” Chou. (2014-present). Division of Pharmaceutical Outcomes and Policy, UNC
Eshelman School of Pharmacy.
2. JaHyun Kang. (2010-2011). UNC School of Nursing.
3. Baozhi “David” Wei. (2009-2011). Division of Pharmaceutical Outcomes and Policy, UNC
Eshelman School of Pharmacy.
4. Patrick B. Ryan. (2008-2010). Division of Pharmaceutical Outcomes and Policy, UNC Eshelman
School of Pharmacy.
5. Andrea Ireland. (2000-2005). Department of Maternal and Child Health.
6. Claire Gibbons. (2000-2003). Department of Maternal and Child Health.
7. Kathryn Andersen Clark. (1998-2000). Department of Maternal and Child Health.
8. Emmanuel M. Ngui. (1998-2001). Department of Maternal and Child Health.
Updated: May 29, 2014 -21-
9. Maryam Navaie-Waliser. (1997-1999). Department of Maternal and Child Health.
MASTER’S STUDENT SUPERVISION (* Indicates Health Policy and Management student, † Indicates other student)
Primary Advisor for Master’s Papers:
1. *Linda Hong (2013-2014). “Cost-effectiveness Analysis of Tofacitinib versus Tumor Necrosis
Faction Inhibitors in Combination with Methotrexate for Rheumatoid Arthritis Patients with
Inadequate Response”. 2014.
2. *Chukwunonso “Anthony” Nwosu (2012-2013). “A Quick Quality Index for Measuring Readiness
of Primary Health Facilities to Deliver Quality Services in Southeastern Nigeria”. 2013
3. *Aditi Krishna (2011-2012). “Moving Cervical Cancer Prevention and Treatment Higher on the
Government of India’s Policy Agenda”. 2012.
4. *Lauren Brown (2009-2010). “Cost-Effectiveness of Vaccination for the Prevention of
Haemophilus Influenzae Type B Disease in Infants and Young Children in the People’s Republic of
China”. 2010.
5. *Gabriele Morosoff (2008-2009). “Cost-effectiveness of Advance Market Commitment for
Pneumococcal Conjugate Vaccines in the Gambia”. 2009.
6. *Cheriann S. Poss (2008-2009). “An Analysis of Reproductive Health and Family Planning Choices
for Community-based Distribution and Clinic-based Clients in Nakasongola, Uganda”. 2009.
7. *Carol Bruxvoort (2007- 2011). “Constitutional Issues Associated with Mandatory HPV
Vaccination among Pre-Teen Girls in the United States”. 2011.
8. *Jesse C. Lichstein (2007-2008). “Cost-Utility Analysis of Sacral Nerve Stimulation and
Botulinum-A for the Treatment of Urinary Urge Incontinence in Women 65 and Older”. 2008.
9. *Janell E. Wright (2007-2008) “A Descriptive Analysis of HIV-Positive Pregnant Women and their
HIV-Positive Partners in North Carolina”. 2008.
10. *Luong Y. “Ly” Nguyen (2006-2007). “Cost-Effectiveness of Integrating Family Planning Services
into Prevention of Mother to Child Transmission of HIV Programs in Cambodia: A Modeling
Study”. 2007.
11. *Lisa Abaid. “Risk of Radiotherapy in the Treatment of Uterine Sarcoma”. 2006.
12. *Kerri Hecox. “Knowledge of Health Risks of Gestational Diabetes Among Women Diagnosed
with Gestational Diabetes”. 2006.
13. *Leslie N. Brown. “A Study of the Effects of an Enhanced Medicaid Maternity Benefit on Birth-
weight Outcomes in West Virginia”. 2005.
14. *Nora Rosenberg. “Cost-Effectiveness of Integrating Acute HIV Detection into Malawian STD
Clinics”. 2005.
15. *Ellen E. Ritze. “A Cost-Effectiveness Analysis of In-Utero Surgery for Spina Bifida”. 2002.
16. *Kristin Goliber. “State Successes in Recruiting Private Providers into Immunization Registries”.
2001.
17. *Liana M. DesHarnais. “An Economic Comparison of Fluoxetine (Prozac) and Hypericum (St.
John’s Wort) for Treatment of Depression”. 2000.
18. *Heather M. Edin. “Changes and Comparisons of Demographics and Cost Drivers of Care in North
Carolina Medicaid Migraineurs: 1990 and 1998”. 2000.
19. *Victoria E. Barghout. “Cost-Effectiveness Analysis of Screening Techniques for the Detection of
Portal Vein Thrombosis and Hepatocellular Carcinoma in Pre-Liver Transplant Patients”. 1999.
20. *Ellen H. Calhoun. “The Prevalence of Antiretroviral Resistance in Women and the Potential Long-
term Effectiveness of Zidovudine and Other Antiretrovirals in the Prevention of Vertical
Transmission”. 1999.
21. *Susan H. Abeln. “An Approach to Modify Care-Seeking Behavior in Low Back Pain: A Proposal
for Cost Containment”. 1997.
Updated: May 29, 2014 -22-
22. *Felicia Gevirtz. “Measuring the Changes in Quality of Life for Persons with Glaucoma: A
Proposal”. 1996.
23. *Amy C. Llewellyn. “Measures of Success: A Preliminary Evaluation of the North Carolina Caring
Program for Children”. 1995.
24. *Catherine M. Stevens. “Access to Health Care for Latinos in North Carolina: A Descriptive
Analysis with Proposals for Reducing Barriers to Care”. 1994.
25. *Jeanna Baugh. “Perspectives on Recertification: Factors Influencing Orthopedic Surgeons”. 1993.
26. *Carol A. Borack. “Effectiveness of Parent-to-Parent Matching for Support: A Pre-Test of the
Instruments for Future Study”. 1993.
27. *Rebecca M. Glover. “Ameliorating Gaps in Coverage for Persons with HIV/AIDS: Short-Run
Policy Recommendations for the Clinton Administration”. 1993.
28. *Sarah D. Thom. “How the ‘Smooth Character’ of Tobacco Industry Tactics Encourages
Addiction”. 1993.
29. *Dona Huang. “An Evaluation of Success: Retrospective Case Studies on Waste Management
Facility Siting/Permitting Objectives vs. Outcomes”. 1992.
30. *Angela C. Kulynych. “The Role of Midwives in Medicaid: A Case for Data Collection”. 1992.
Secondary Reader for Master’s Papers:
1. *Diep T. Nguyen. “Modelling the Transmission Dynamics of Lymphatic Filariasis: Evaluating
Impact of Combining Doxycycline Regimen with Mass Drug Administration”. 2014.
2. *Makenzie McIntosh. “Cost-Effectiveness of Selected Contraceptive Programs for Adolescents in
North Carolina”. 2013.
3. †Sylvia I. Becker-Dreps. “Cost-Effectiveness of Bednet Distribution at an Antenatal Clinic in
Kinshasa, DRC”. Health Care and Prevention, 2007.
4. †Christopher E. Cox. “Cost-Effectiveness Analysis of Doppler Ultrasound to Detect Embolism in
Patients with Femoral Vein Catheterization”. Health Care and Prevention, 2002.
5. †C. Jeanne Lee. “Cost-Utility of Endovascular Coil Embolization for Aneurysmal Subarachnoid
Hemorrhage: A Decision Analysis Using a Markov Model”. Health Care and Prevention, 2001.
6. *Scott Stewart. “Cost-Effectiveness of Nevirapine for the Prevention of Vertical Transmission of
HIV-1”. 2001.
7. *William O. Fleming. “The Cost-Utility and Policy Implications of Early Initiation of Triple
Combination Therapy for the North Carolina AIDS Drug Assistance Program”. 1999.
8. *Robin S. Burke. “Senior Alternatives for Independent Living: Evaluating Patient Satisfaction in a
North Carolina Home- and Community-Based Long Term Care Project”. 1998.
9. *Susan L. Hogue. “Assessment of a Tool to Measure Patient Functional Disability Following
Outpatient Surgery”. 1998.
10. †Allison B. Rosen. “Cost-Effectiveness of Transesophageal Echocardiography in Determining the
Duration of Therapy for Patients with Intravascular Catheter-Associated Staphylococcus aureus
Bacteremia”. Interdisciplinary Curriculum in Public Health Leadership, 1998.
11. *Heidi Y. Yeager. “HIV Testing for Pregnant Women: Public Health and Individual Rights”. 1997.
12. *Sarah Boyce Fasick. “Management of Urinary Incontinence among the Community-Dwelling
Elderly”. 1997.
13. *Vandana Mishra. “Strengthening Delivery of Health Care Services at the Block Level in
Rajasthan”. Executive Program in Health and Population for Developing Countries. 1996.
14. *Eleanor Dehoney. “The Dimensions and Effects of Medicaid Nursing Home Payment: What Do
We Know?” 1993.
15. *Julie J. Mohr. “An Evaluation of Strategies to Reduce the Rate of Unnecessary Cesarean
Sections”. 1993.
16. †Yvonne Butler. “Understanding Intention-Behavior Consistency with respect to Infant Feeding: An
Application of Reasoned Action”. Department of Health Behavior and Health Education, 1992.
17. *Gary L. Freed. “Adoption of a New Haemophilus influenzae type b Vaccine Recommendation by
Pediatricians”. 1992.
Updated: May 29, 2014 -23-
18. †Catherine B. Mills. “The WIC Infant Feeding Study: A Qualitative Evaluation”. Department of
Health Behavior and Health Education, 1992.
Master’s Theses:
1. †Kevin O’Shaughnessy. “Serial Extraction vs. Late Premolar Extraction: A Study of Cost-
Effectiveness”, Orthodontics, UNC School of Dentistry, 2007.
2. †Ahmad-Rufai Abdullah. “A Study of the Public Health Significance of September 11th on the
Muslim Communities in Raleigh, North Carolina Using Photovoice”. 2004. 3. †Birgitta M. vonScheele. “A Cost-Effectiveness Study of Carbetocin Compared to Oxytocin for the
Prevention of Uterine Atony after Cesarean Section”. Division of Pharmaceutical Policy and
Evaluative Sciences, School of Pharmacy, 2000.
4. †Ping C. Chen. “Cost-Benefit Analysis of Risperidone versus Haloperidol in the Treatment of
Schizophrenia”. Division of Pharmaceutical Policy and Evaluative Sciences, School of Pharmacy,
1999.
BACCALAUREATE HONORS THESIS SUPERVISION (* Indicates Health Policy and Management student, † Indicates other student)
Primary Advisor:
1. *Victor Leclere. “The Role of Community-Based Health Insurance in Chronic Disease Care
Management: A Case Feasibility Study on Diabetes Care Management through Mutual Health
Organizations in Dakar, Senegal”. 2012.
2. *Crawford R. Nelson. “Micro health insurance: A systematic literature review and history”.
Baccalaureate Honor’s Thesis, Highest Honors, 2010.
3. †Kathryn E. Long. “Obstetrical Care: The Crisis in Catawba County, North Carolina”.
Baccalaureate Honor’s Thesis, Curriculum in Public Policy Analysis, Highest Honors, 1994.
4. *Jack Mensch. “Meeting the Future Demand for Geriatric Long-term Care in the United States”.
1993.
Secondary Reader:
1. *Rina Khemlani. “Analysis of the Saheli Project: An HIV/AIDS Education Intervention in
Bombay”. 1999.
2. *Carrie L. Alden. “An Analysis of the Governing Board’s Function: Do They Make A Difference?”
1998.
3. *Seon Kyung Judy Kim. “Interorganizational Relationships: A Case Study of the Stakeholders
Group Formed on Behalf of the Transition to Chlorofluorocarbon-free Metered Dose Inhalers”. 1997.
4. †Todd Rose. “The Effect of the Omnibus Budget Reconciliation Act of 1990 on Retail
Pharmaceutical Prices”. Curriculum in Public Policy Analysis, 1996.
RESEARCH GRANT FUNDING
1. The Nationwide Study of Female Sexual Health PI: Suzanne L. West
Co-Investigator/Health Economist: Andrea K. Biddle
Proctor & Gamble Pharmaceuticals
$650,000
2004-2005
Updated: May 29, 2014 -24-
2. Targeting Acute HIV PI: Christopher Pilcher
Co-Investigator/Health Economist: Andrea K. Biddle
National Institute of Mental Health
$1,599,975
2003-2008
3. Symptom Focused Diabetes Care for African American Women PI: Anne H. Skelly
Co-Investigator/Health Economist: Andrea K. Biddle
National Institute for Nursing Research
$1,684,767
2003-2005
4. Quit-Smoking Program for Lung Cancer Patient Families PI: Andrea K. Biddle
National Cancer Institute
$221,032
2003-2008
5. Cancer Prevention in Beauty Salons: Tailor or Train? PI: Lauran A. Linnan
Co-Investigator/Health Economist: Andrea K. Biddle
American Cancer Society
$1,171,520
2002–2006
6. UNC Center for Education and Research on Therapeutics Competitive Continuation: Rational
Therapeutics for the Pediatric Population PI: W.H. Campbell
Co-Investigator/Health Economist: Andrea K. Biddle
Agency for Healthcare Research and Quality
Annual Direct Costs 04 Year $579,454
2002-2007
7. A Nursing Support Intervention for Mothers of Prematures PI: Diane Holditch-Davis
Health Economist: Andrea K. Biddle.
National Institute of Nursing Research.
$1,750,000
2002-2006.
8. Health Communications in Cancer Control PI: Marci K. Campbell
Health Economist: Andrea K. Biddle.
National Cancer Institute.
$1,548,353
1999-2003.
9. *Evidence Based Practice Center Task Order on Criteria for the Determining Disability in
Speech and Language Disorders PI: Kathleen Lohr (Research Triangle Institute) and Timothy Carey (UNC-CH Sheps Center) and
Updated: May 29, 2014 -25-
Project Director: Andrea K. Biddle.
Agency for Healthcare Research and Quality.
$250,000 (main and UNC-CH subcontract)
2000-2002
10. *Patient Perspectives on Health Insurance PI: Andrea K. Biddle
Department of Clinical Bioethics, National Institutes of Health
$36,646
2000
11. Dissemination of Clinical Practice Guidelines for Spinal Cord Injury Medicine. PI: Lucy A. Savitz and Co-Investigator: Andrea K. Biddle.
Paralyzed Veterans of America.
$74,710
1998-1999
12. *Methodological Support for Spinal Cord Injury Medicine Clinical Practice Guideline
Development PanelsYear 2. PI: Andrea K. Biddle.
Paralyzed Veterans of America.
$110,000
1998-1999
13. *Literature Review and Data Analytic Support Services for AIDS and Cancer. PI: Andrea K. Biddle.
Chiron Diagnostics, Inc.
$30,000
1997-1999
14. Evidence Based Practice Center Task Order on the Efficacy of Pharmacological Treatment of
Substance Abuse. PI: Kathleen Lohr (Research Triangle Institute) and Gordon DeFriese (UNC-CH Sheps Center)
and Investigator: Andrea K. Biddle.
Agency for Health Care Policy and Research.
$250,000 (main and UNC-CH subcontract)
1997-1998
15. *Pediatric Allergy Learning Study (PALS): An Evaluation of the Effects of Claritin on
Seasonal Allergic Rhinitis and Associated Emotional and School Performance Impairments in
Children Who are At Least 7 and Less than 10 Years of Age: An Analysis of Health-Related
Quality of Life and Resource Utilization. PI: Andrea K. Biddle and Co-PI: Kit N. Simpson.
Advanced Clinical Epidemiological Research, Schering-Plough.
$47,996
1997-1998
16. Assessing Costs of Childhood Immunization Registry Systems. PI: Gordon DeFriese and Co-Investigators: Andrea K. Biddle, Victoria A. Freeman, and Rebecca
T. Slifkin.
Robert Wood Johnson All Kids Count Program.
$48,678
1997
Updated: May 29, 2014 -26-
17. *Cost of Illness for Patients with AIDS and Other Severe Chronic Conditions: A Multinational
Comparison. PI: Andrea K. Biddle and Co-PI: Kit N. Simpson.
Glaxo-Wellcome, Inc.
$52,494
1996-1997
18. *Methodological Support for Spinal Cord Injury Medicine Clinical Practice Guideline
Development Panels. PI: Andrea K. Biddle.
Paralyzed Veterans of America.
$80,000
1996-1998
19. *Do Government Vaccine Programs Affect Child Vaccine Charges and Provider Behavior? PI: Gary L. Freed and Co-Investigators: Andrea K. Biddle, T. Robert Konrad, and Donald E.
Pathman.
Centers for Disease Control and Prevention.
$302,830
1994-1996
20. *Validation of an Instrument to Study Medicare Beneficiary Insurance Choices. PI: Andrea K. Biddle.
University Research Council, UNC-Chapel Hill.
$1,475
1995-1997
21. *The Growing Number of Uninsured: Estimating the Effect of Changes in Family Structure
and Employment Patterns. PI: Andrea K. Biddle and Co-PI: Kenneth E. Thorpe.
The Commonwealth Fund.
$219,345
1992-1995
22. A Model for Estimating the Impact of Children’s Vaccine Initiative Research Investment
ChoicesPhase II. PI: Kit N. Simpson and Co-Investigator: Andrea K. Biddle.
Division of Microbiology and Infectious Diseases, National Institute for Allergy and Infectious
Diseases.
$24,950
1992-1993
23. CVD Nutrition Modules Tailored to Low Literacy Skills. PI: Victor C. Strecher and Co-Investigators: Alice Ammerman, Andrea K. Biddle, Gerardo Heiss,
and Thomas Keyserling.
National Heart, Lung, and Blood Institute.
$2,445,612
1991-1996
24. Evaluation of the Advocare Project. PI: Andrea K. Biddle and Co-PI: Jane D. Pitcher.
American Foundation for AIDS Research jointly to the AIDS Service Agency of Wake County
Updated: May 29, 2014 -27-
and The AIDS Service Project (of Durham).
$3,000 (evaluation subcontract, total grant $50,000)
1992-1993.
25. A Model for Estimating the Impact of Children’s Vaccine Initiative Research Investment
ChoicesPhase I. PI: Kit N. Simpson and Co-Investigator: Andrea K. Biddle.
Division of Microbiology and Infectious Diseases, National Institute for Allergy and Infectious
Diseases.
$37,000
1991-1992
26. The Adoption and Implementation of HIV Partner Notification Programs. PI: Andrea K. Biddle.
The RAND Corporation.
$30,000
1989-1990
27. A Prospective Analysis of the Cost-Effectiveness of Safety Belts in Texas School Buses. PI: Charles E. Begley and Co-PI: Andrea K. Biddle.
Center for Health and Manpower Studies, The University of Texas at Houston.
$2,500
1986
OTHER RESEARCH PROJECTS
1. *The Cost-Effectiveness of Serial Fecal Occult Blood Testing. PI: Mark W. Russo and Co-Investigators: Andrea K. Biddle, and Robert S. Sandler.
1 July 1997-30 June 1998.
2. *The Preventability of Critical Illness in Children. PI: Gary Duhon and Co-PI: Andrea K. Biddle.
1 January 1997-30 June 1997.
3. *Relationship of Breastfeeding Duration and Intensity and Sudden Infant Death Syndrome. PI: Doren Fredrickson and Co-PIs: Andrea K. Biddle, Nicholas Ngandu, James Sorenson, and
Milton Kotelchuck.
1992-1993.
RESEARCH CONSULTATIONS
1. IntraHealth International, Chapel Hill, NC. Consultation and peer-review of manuscripts for
global health and economic modeling. Contact Person: Laura Gibney, PhD, Chapel Hill, NC, June
2011-2012.
2. Abt Associates, Durham, NC. Consultation and peer-review of manuscripts for global health and
economic modeling. Contact Person: Bernadette Marriott, PhD, Durham, NC, August 2008-2011.
3. Amgen, Inc., Thousand Oaks, CA. Consultation on economic analysis and modeling. Contact
Person: David J. Harrison, PhD, Thousand Oaks, CA, October 2006-December 2006.
4. GlaxoSmithKline, Research Triangle Park, NC. Consultation on economic analysis and modeling.
Contact Person: Maria E. Watson, PhD, Research Triangle Park, NC, January 2002-August 2002.
Updated: May 29, 2014 -28-
5. The Lewin Group, Falls Church, VA. Technical review of economic model for confidential client.
Contact Person: Eric Gemmen, PhD, Falls Church, VA, January 2002-August 2002.
6. Health Strategies Group/Allina Medical Foundation, Minneapolis, MN. Data entry/analysis and
manuscript preparation for the Minnesota CHAT: Public Perspectives on Health Insurance in
Minnesota project (part of the Allina Health System Reform Study). Contact Person: Ellen
Benavides, MHA, Minneapolis, MN, May 2000-September 2000.
7. Boehringer Ingelheim GmbH. Consultation concerning the development of economic models for a
new AIDS drug for Canada, France, Germany, Italy, Spain, the United Kingdom, and the United
States. Contact persons: Marianne Greer, Ph.D., Ridgebury, Connecticut and Peter Koch, Ingelheim,
Germany. May 1997-November 1998.
8. Gay and Lesbian Health Project and the AIDS Service Agency of Wake County. Consultation
on the development of an evaluation plan for the Advocare Project. Contact Persons: Stan Holt,
Durham, North Carolina and Cullen Gurganis, Raleigh, North Carolina. December 1991-November
1993.
PROFESSIONAL SERVICE
SERVICE TO DISCIPLINE
State and Local Service to Discipline:
1. Member, Orange County Task Force on Childhood Immunization, 1996-1997.
2. Conference Organizer and Moderator, "Preparing for Medicaid Managed Care: The Role for the
Hospital and Healthcare Executive", Triangle Healthcare Executives' Forum/Department of Health
Policy and Administration, Chapel Hill, North Carolina, 16 November 1995.
3. Coordinator, In-Service Workshop on Medicaid Managed Care, presented to the North Carolina
Division of Medical Assistance, North Carolina Department of Human Resources, Raleigh, North
Carolina, 16 November 1995.
4. Member, North Carolina Public Health Association, 1992-1994.
5. Evaluator for the Lesbian and Gay Health Project (Durham) and the AIDS Service Agency of
Wake County (Raleigh), 1992-1993.
National Service to Discipline:
1. Workshop Presenter, “Economic Evaluation: A Primer for Genomics”. Lecture for “Applications
of Genomics to Public Health Challenges”. Training course sponsored by the Social and Behavioral
Research Branch of the National Institutes of Health, May 19, 2014.
2. Workshop Presenter, “Economic Evaluation: A Primer for Genomics”. Lecture for “Applications
of Genomics to Public Health Challenges”. Training course sponsored by the Social and Behavioral
Research Branch of the National Institutes of Health, May 23, 2012.
3. Advisory Board Member, Advance Health Solutions, La Jolla, CA, 2008-present.
4. Scientific Grant Reviewer, Evidence-Based Medicine Center, Agency for Healthcare Research and
Quality, 2002.
5. Manuscript Reviewer for 6 Scholarly Journals (see the Research Section of this Curriculum Vitae
for details).
6. Co-Organizer, Joint Conference on Conjoint Analysis, sponsored by UNC-CH, Medical University
of South Carolina, RTI International, and McMaster University, 26 September 2001 in Chapel Hill,
NC
Updated: May 29, 2014 -29-
7. Methodological Consultant, Department of Veterans Affairs, Spinal Cord Injury Quality
Enhancement Research Initiative Advisory Group, 1999-2000.
8. Methodological Advisor for Intramural Proposals, National Institutes of Health, Division of
Clinical Bioethics, 1998-present.
9. Peer-Reviewer of Colleague for Appointment as Full Professor, review of Dr. Kit N. Simpson for
appointment at the College of Pharmacy, Medical University of South Carolina, 1998.
10. Peer-Reviewer, Research Triangle Institute and the Maternal and Child Health Bureau, provided
peer- review of “An Introduction to Economic Analysis for MCH Practitioners” prepared for HRSA
and the Maternal and Child Health Bureau under Contract #240-97-0033, 1998.
11. Methodologic Consultant, Spinal Cord Medicine Consortium and the Tampa Veterans Affairs
Medical Center, Working Group on Implementation and Evaluation, 1997-1998.
12. Steering Committee Member, Consortium for Spinal Cord Medicine Clinical Practice Guidelines
Initiative, 1996-1999.
13. Membership Co-Chair, Health Administration Section, American Public Health Association, 1992-
1993.
14. Session Organizer and Presider, Health Administration Section Student Roundtable Session,
American Public Health Association Annual Meeting, Chicago, Illinois, 1993.
15. Peer Reviewer of Abstracts, Health Care Administration Division, Academy of Management
Annual Meeting, 1993.
16. Membership in Various National Professional Associations and Societies Applied Research Ethics National Association, 2003-2006.
Public Responsibility in Research and Medicine, 2003-2006.
AcademyHealth (formerly Association for Health Services Research), 1990-present.
Association of Public Policy and Management, 1989-2000.
Association for the Social Sciences in Health, 1986-1991.
American Public Health Association, 1984-1999.
International Service to Discipline:
1. Abstract Reviewer, Society for Medical DecisionMaking Annual Meeting, June 2014.
2. Abstract Reviewer, International Society for Pharmacoeconomics and Outcomes Research,
European Annual Meeting, May 2014.
3. Abstract Reviewer, International Society for Pharmacoeconomics and Outcomes Research,
International Annual Meeting, February 2014.
4. Abstract Reviewer, Society for Medical DecisionMaking Annual Meeting, June 2013.
5. Abstract Reviewer, International Society for Pharmacoeconomics and Outcomes Research,
European Annual Meeting, May 2013.
6. Abstract Reviewer, International Society for Pharmacoeconomics and Outcomes Research,
International Annual Meeting, February 2013.
7. Abstract Reviewer, International Society for Pharmacoeconomics and Outcomes Research,
European Annual Meeting, May 2012.
8. Abstract Reviewer, International Society for Pharmacoeconomics and Outcomes Research,
International Annual Meeting, February 2012.
9. Abstract Reviewer, Society for Medical DecisionMaking Annual Meeting, July 2011.
10. Manuscript Reviewer for 3 International Scholarly Journal (see the Research Section of this
Curriculum Vita for details).
11. Member, Task Force on Good Research Practices—Modeling Studies, ISPOR Health Science
Committee, 2000-2001
12. Workshop Co-Coordinator, International Society for Pharmacoeconomics and Outcomes Research
Annual Meeting, Crystal City, Virginia, 25 May 1999.
13. Workshop Organizer and Presenter, in collaboration with the College of Nurses of Ontario, for the
18th Annual Conference of the Council on Licensure, Regulation, and Enforcement, Denver Colorado,
19 September 1998.
Updated: May 29, 2014 -30-
14. Cochrane Collaborative Review Group on Brain and Spinal Cord Injury Member, United
Kingdom Cochrane Center, 1996-1999.
15. Membership in Various International Professional Organizations and Societies Health Technology Assessment International (formerly ISTAHC), 2003-present.
International Health Economics Association, 2002-present.
Society for Medical DecisionMaking, 2002-present.
International Society for Pharmacoeconomics and Outcomes Research, 2000-present.
International Society for Technology Assessment in Health Care (ISTAHC) 1996-2003.
SERVICE TO THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
Membership on Committees Outside of the School of Public Health:
1. Member, Chancellor’s Advisory Committee, 2012-present.
2. Chair, University Task Force on the Evaluation of the Priority Registration System, 2011-2012.
3. Member, Faculty Committee Nominating Committee, 2011-2013.
4. Chair, UNC Educational Policy Committee, 2010-2012.
5. Member, Faculty Steering Committee, Certificate on International Development, 2009-present.
6. Member, UNC Educational Policy Committee, 2008-present.
7. Member, Office of Human Research Ethics (OHRE) Educational Activities and Class Projects Task
Group, 2006.
8. Member, Provost’s Task Force on Conflict of Interest, 2005-2006.
9. Member, OHRE Information Systems Development and Implementation Task Group, 2005-2006.
10. Member, Office of Human Research Ethics [OHRE] Advisory Board, 2004-2006.
11. Lecturer, Campus HIPAA and Research Education Initiative (3/4/2003 & 4/24/2003)
12. Member, OHRE Standard Operating Procedures Task Group, 2003.
13. Member, UNC-CH OHRE, Public Health-Nursing Institutional Review Board, 2002-2008.
14. Reviewer, Conference ProceedingsStandards for Economic Evaluation of Drugs: Issues and
Answers, CePOR, Center for Pharmaceutical Outcomes Research, School of Pharmacy, 1995.
15. Center Staff, Center for Pharmaceutical Outcomes Research, School of Pharmacy, 1995.
16. Center Associate, Cecil G. Sheps Center for Health Services Research, University of North Carolina
at Chapel Hill, North Carolina, 1993-present.
17. Member, Dean's Task Force on Women’s Health Task Force Member, UNC-CH School of
Medicine, 1993-1995.
Membership on School of Public Health Committees:
1. Member, Schoolwide Award Committee, 2013-present.
2. Member, Gillings-SPH Financial Literacy Committee, 2007-2010.
3. Member, Search Committee for Director of Program Management, Carolina Public Health Solutions,
2008.
4. Instructor and Faculty Coordinator (2008), UNC-Malawi Summer Institute, 2006-2009.
5. Member, Malawi Summer Institute Selection Committee, Office of Global Health, 2006-2009.
6. Chair, Public Health Institutional Review Board, 2004-2006.
7. Coordinator, Public Health Institutional Review Board Continuing Education Program, May 2004.
8. Deputy Chair, Public Health Institutional Review Board, 2002-2004.
9. Member, Theta Chapter, Delta Omega Award Selection Committee, 2003-present.
10. Member, Greenberg Dissertation Award Selection Committee Member, 2000-2001.
11. Member, Public Health-Nursing Institutional Review Board, 2001-2006.
Membership on Committees within the Department of Health Policy and Management:
Updated: May 29, 2014 -31-
1. Member, Masters Advisory Committee, 2014-present.
2. Member, Executive Committee, 2010-present.
3. Chair, Global Health Committee, 2010-2011.
4. Member, Global Health Committee (formerly Global Health Work Group), 2007-2011.
5. Examiner, Ph.D. Health Services Research Comprehensive Examinations, 2010-2012.
6. Examiner, Ph.D. Decision Science Minor Comprehensive Examinations 2006-present.
7. Examiner, Master’s Student Comprehensive Examinations 2006-present.
8. Reviewer, MHA Capstone Presentations, 2006-present.
9. Decision Sciences Minor Representative, Ph.D. Advisory Committee, 2003-present.
10. Coordinator, HPAA Master’s Paper and Senior Honor Thesis Poster Day, 2001, 2003.
11. Member, Faculty Search Committee Member, 2000-2004, 2005-2006.
12. Ad hoc Committee on the Quality Measurement and Management Concentration Member,
January 2001-2004.
13. Member, Master’s Program Advisory Committee Member, 2001-2004.
14. Panelist, Health Policy Professions Panel, 2000-2001.
15. Member, Implementation of Recommendations of the HPAA Faculty Retreat Steering Committee,
2000-2003.
16. Faculty Mentor for Teaching Fellow, Departmental Preparatory Mathematics Module, 1998-2003.
17. Member, MSPH Curriculum Review Committee, 1996-2003.
18. Conference Session Organizer and Moderator, “Medicaid Managed Care: Experiences from the
Front Lines and Expectations for the Future”. Annual Preceptor’s Conference, Department of Health
Policy and Administration, Chapel Hill, North Carolina, 17 November 1996.
19. Developer, Departmental Teaching Peer-Review Form and Guidelines, 1996.
20. Preparer, Statistical Analysis of HPAA Bachelor of Science in Public Health Incoming Class, 1996.
21. Member, Master of Healthcare Administration Curriculum Review Committee, 1995-1997.
22. Member, Academic Standards Committee, 1994-2004.
23. Preparer, Master’s Degree Qualifying Examination Questions, 1992-2003.
24. Chair, Computer Advisory Committee, 1992-1994, 1996.
25. Member, Computer Advisory Committee Member, 1992-1997.
26. Member, Admissions Committee, 1992-1994.
27. Member, Ad hoc Grade Grievance Committee, 1992. Other Types of University Service at UNC-Chapel Hill: 1. Mentor, Womentoring Program, 1996. 2. Member, Association for Women Faculty and Professions, 1995-2005.